Skip to main content Accessibility help
  • Print publication year: 2000
  • Online publication date: June 2014

Chapter 36 - Diseases of the pleura



The pleura is host to many diseases, some systemic, others spreading from the underlying lung. Lung carcinoma metastases are the commonest lesions seen by pathologists. The most frequent cause of pleural problems is an effusion, secondary to congestive cardiac failure. This chapter will consider normal pleural physiology, as well as benign and malignant processes.

The pleural space, separating the lung and chest wall, contains a small amount of liquid that lubricates the pleural surfaces during breathing (see Chapter 1). The volume of fluid in the pleural space is small, in the range of 0.2–0.5 ml. Normally, the protein and cellular content is low, with no inflammatory cells. The thin layer of liquid between the pleural surfaces has the important function of providing mechanical coupling between the chest wall and lung. For this connection to be effective, the volume of pleural liquid required for lubrication must be kept to a minimum. In addition, the colloid osmotic pressure must be low to keep this volume small. This fluid ensures instantaneous transmission of perpendicular forces between the two structures, and allows their sliding movement in response to shearing forces.

Jantz, MA, Antony, VB.Pathophysiology of the pleura. Respiration 2008;75(2):121–33.
Agostoni, E.Mechanics of the pleural space. Physiol Rev 1972;52(1):57–128.
Lai-Fook, SJ.Pleural mechanics and fluid exchange. Physiol Rev 2004;84(2):385–410.
Gaudio, E, Rendina, EA, Pannarale, L, Ricci, C, Marinozzi, G.Surface morphology of the human pleura. A scanning electron microscopic study. Chest 1988;93(1):149–53.
Peng, MJ, Vargas, FS, Cukier, A, Terra-Filho, M, Teixeira, LR.Light RW. Postoperative pleural changes after coronary revascularization. Comparison between saphenous vein and internal mammary artery grafting. Chest 1992;101(2):327–30.
Miserocchi, G, Sancini, G, Mantegazza, F, Chiappino, G.Translocation pathways for inhaled asbestos fibers. Environ Health 2008;7:4.
Lai-Fook, SJ, Rodarte, JR.Pleural pressure distribution and its relationship to lung volume and interstitial pressure. J Appl Physiol 1991;70(3):967–78.
Agostoni, E, Zocchi, L.Pleural liquid and its exchanges. Respir Physiol Neurobiol 2007;159:311–23.
Zocchi, L.Physiology and pathophysiology of pleural fluid turnover. Eur Respir J 2002;20(6):1545–58.
Noppen, M, De Waele, M, Li, R, et al. Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. Am J Respir Crit Care Med 2000;162(3 Pt 1):1023–6.
Jaurand, M, Fleury-Feith, J, Bernaudin, J, Bignon, J.Pleural mesothelial cells. In Crystal, R, West, J, eds. The Lung: Scientific Foundations. Philadelphia: Raven, 1997. pp. 961–9.
Wang, NS.Anatomy of the pleura. Clin Chest Med 1998;19(2):229–40.
Antony, VB, Sahn, SA, Mossman, B, Gail, DB, Kalica, A.NHLBI workshop summaries. Pleural cell biology in health and disease. Am Rev Respir Dis 1992;145(5):1236–9.
Kroegel, C, Antony, VB.Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 1997;10(10):2411–8.
Ohtsuka, A, Yamana, S, Murakami, T.Localization of membrane-associated sialomucin on the free surface of mesothelial cells of the pleura, pericardium, and peritoneum. Histochem Cell Biol 1997;107(6):441–7.
Sassetti, C, Van Zante, A, Rosen, SD.Identification of endoglycan, a member of the CD34/podocalyxin family of sialomucins. J Biol Chem 2000;275(12):9001–10.
Gupta, KB, Mishra, DS, Tandon, S, Sindhwani, G, Tanwar, T.Role of chest CT scan in determining etiology of primary spontaneous pneumothorax. Indian J Chest Dis Allied Sci 2003;45(3):173–7.
Owens, MW, Milligan, SA, Grisham, MB.Nitric oxide synthesis by rat pleural mesothelial cells: induction by growth factors and lipopolysaccharide. Exp Lung Res 1995;21(5):731–42.
Owens, MW, Grisham, MB.Nitric oxide synthesis by rat pleural mesothelial cells: induction by cytokines and lipopolysaccharide. Am J Physiol 1993;265(2 Pt 1):L110–6.
Delves, PJ, Roitt, IM.The immune system. Second of two parts. N Engl J Med 2000;343(2):108–17.
Broaddus, V.Physiology:fluid and solute exchange in normal physiological states. In Light, RW, Lee, Y, eds. Textbook of Pleural Disease. London: Hodder Arnold, 2008. pp. 43–8.
Mulvey, RB.The effect of pleural fluid on the diaphragm. Radiology 1965;84:1080–6.
Light, RW, Macgregor, MI, Luchsinger, PC, Ball, WC Jr.Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972;77(4):507–13.
Heffner, JE, Brown, LK, Barbieri, CA.Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators. Chest 1997;111(4):970–80.
Sahn, SA.Approach to patients with pleural disease. In Light, RW, Lee, Y, eds. Textbook of Pleural Disease. London: Hodder Arnold, 2008. pp. 201–8.
Kinasewitz, GT.Transudative effusions. Eur Respir J 1997;10(3):714–8.
Natanzon, A, Kronzon, I.Pericardial and pleural effusions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations. Am J Med Sci 2009;338(3):211–6.
Wiener-Kronish, JP, Goldstein, R, Matthay, RA, et al. Lack of association of pleural effusion with chronic pulmonary arterial and right atrial hypertension. Chest 1987;92(6):967–70.
Porcel, JM.Establishing a diagnosis of pleural effusion due to heart failure. Respirology 2009;14(4):471–3.
Kiafar, C, Gilani, N.Hepatic hydrothorax: current concepts of pathophysiology and treatment options. Ann Hepatol 2008;7(4):313–20.
Lieberman, FL, Hidemura, R, Peters, RL, Reynolds, TB.Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med 1966;64(2):341–51.
Kashani, A, Landaverde, C, Medici, V, Rossaro, L.Fluid retention in cirrhosis: pathophysiology and management. QJM 2008;101(2):71–85.
Finn, R, Jowett, EW.Acute hydrothorax complicating peritoneal dialysis. Br Med J 1970;2(5701):94.
Rudnick, MR, Coyle, JF, Beck, LH, McCurdy, DK.Acute massive hydrothorax complicating peritoneal dialysis, report of 2 cases and a review of the literature. Clin Nephrol 1979;12(1):38–44.
Townsend, R, Fragola, JA.Hydrothorax in a patient receiving continuous ambulatory peritoneal dialysis: successful treatment with intermittent peritoneal dialysis. Arch Intern Med 1982;142(8):1571–2.
Kim, YL, Cho, YJ, Park, SH, et al. Peritoneal-mediastinal leakage complication of peritoneal dialysis. Am J Kidney Dis 2003;42(2):E17–9.
Leung, FW, Williams, AJ, Oill, PA.Pleural effusion associated with urinary tract obstruction: support for a hypothesis. Thorax 1981;36(8):632–3.
Carcillo, J Jr, Salcedo, JR.Urinothorax as a manifestation of nondilated obstructive uropathy following renal transplantation. Am J Kidney Dis 1985;5(3):211–3.
Cavina, C, Vichi, G.[Radiological aspects of pleural effusions in medical nephropathy in children.]. Ann Radiol Diagn (Bologna) 1958;31(3):163–202.
Sahn, SA.State of the art. The pleura. Am Rev Respir Dis 1988;138(1):184–234.
Light, RW, George, RB.Incidence and significance of pleural effusion after abdominal surgery. Chest 1976;69(5):621–5.
Heffner, JE, Sahn SA. Pleural disease in pregnancy. Clin Chest Med 1992;13(4):667–78.
Hughson, WG, Friedman, PJ, Feigin, DS, Resnik, R, Moser, KM.Postpartum pleural effusion: a common radiologic finding. Ann Intern Med 1982;97(6):856–8.
Sahn, SA.Malignancy metastatic to the pleura. Clin Chest Med 1998;19(2):351–61.
Porcel, JM, Martinez-Alonso, M, Cao, G, et al. Biomarkers of heart failure in pleural fluid. Chest 2009;136(3):671–7.
van Gelder, T, Hoogsteden, HC, Vandenbroucke, JP, van der Kwast, TH, Planteydt, HT.The influence of the diagnostic technique on the histopathological diagnosis in malignant mesothelioma. Virchows Arch A Pathol Anat Histopathol 1991;418(4):315–7.
Krakowka, P, Rowinska, E, Halweg, H.Infection of the pleura by Aspergillus fumigatus. Thorax 1970;25(2):245–53.
Colp, CR, Cook, WA.Successful treatment of pleural aspergillosis and bronchopleural fistula. Chest 1975;68(1):96–8.
Irani, FA, Dolovich, J, Newhouse, MT.Bronchopulmonary and pleural aspergillosis. Am Rev Respir Dis 1971;103(4):552–6.
Heidecker, J, Kaplan, A, Sahn, SA.Pleural fluid and peripheral eosinophilia from hemothorax: hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. Am J Med Sci 2006;332(3):148–52.
Katayama, H, Yokoyama, A, Kohno, N, et al. Production of eosinophilic chemokines by normal pleural mesothelial cells. Am J Respir Cell Mol Biol 2002;26(4):398–403.
Moskowitz, H, Platt, RT, Schachar, R, Mellins, H.Roentgen visualization of minute pleural effusion. An experimental study to determine the minimum amount of pleural fluid visible on a radiograph. Radiology 1973;109(1):33–5.
Mitrouska, I, Klimathianaki, M, Siafakas, NM.Effects of pleural effusion on respiratory function. Can Respir J 2004;11(7):499–503.
Noppen, M, De Keukeleire, T.Pneumothorax. Respiration 2008;76(2):121–7.
Gupta, D, Hansell, A, Nichols, T, Duong, T, Ayres, JG, Strachan, D.Epidemiology of pneumothorax in England. Thorax 2000;55(8):666–71.
Sahn, SA, Heffner, JE.Spontaneous pneumothorax. N Engl J Med 2000;342(12):868–74.
Melton, LJ 3rd, Hepper, NG, Offord, KP.Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis 1979;120(6):1379–82.
Bense, L, Eklund, G, Wiman, LG.Smoking and the increased risk of contracting spontaneous pneumothorax. Chest 1987;92(6):1009–12.
Bradley, M, Williams, C, Walshaw, MJ.The value of routine expiratory chest films in the diagnosis of pneumothorax. Arch Emerg Med 1991;8(2):115–6.
Amjadi, K, Alvarez, GG, Vanderhelst, E, et al. The prevalence of blebs or bullae among young healthy adults: a thoracoscopic investigation. Chest 2007;132(4):1140–5.
Lesur, O, Delorme, N, Fromaget, JM, Bernadac, P, Polu, JM.Computed tomography in the etiologic assessment of idiopathic spontaneous pneumothorax. Chest 1990;98(2):341–7.
Ohata, M, Suzuki, H.Pathogenesis of spontaneous pneumothorax. With special reference to the ultrastructure of emphysematous bullae. Chest 1980;77(6):771–6.
Hatz, RA, Kaps, MF, Meimarakis, G, Loehe, F, Muller, C, Furst, H.Long-term results after video-assisted thoracoscopic surgery for first-time and recurrent spontaneous pneumothorax. Ann Thorac Surg 2000;70(1):253–7.
Schramel, F, Meyer, CJ, Postmus, P.Inflammation as a cause of spontaneous pneumothorax and emphysema-like changes: results of bronchoalveolar lavage. Eur Respir J 1995;8:397s.
Bense, L, Eklund, G, Wiman, LG.Bilateral bronchial anomaly. A pathogenetic factor in spontaneous pneumothorax. Am Rev Respir Dis 1992;146(2):513–6.
Withers, JN, Fishback, ME, Kiehl, PV, Hannon, JL.Spontaneous pneumothorax. Suggested etiology and comparison of treatment methods. Am J Surg 1964;108:772–6.
Coxson, HO, Chan, IH, Mayo, JR, et al. Early emphysema in patients with anorexia nervosa. Am J Respir Crit Care Med 2004;170(7):748–52.
Bolliger, CT, Mathur, PN, Beamis, JF, et al. ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J 2002;19(2):356–73.
Alifano, M, Forti, Parri SN, Bonfanti, B, et al. Atmospheric pressure influences the risk of pneumothorax: beware of the storm!Chest 2007;131(6):1877–82.
Sundaram, S, Tasker, AD, Morrell, NW.Familial spontaneous pneumothorax and lung cysts due to a Folliculin exon 10 mutation. Eur Respir J 2009;33(6):1510–2.
Huang, TW, Cheng, YL, Tzao, C, et al. Factors related to primary bilateral spontaneous pneumothorax. Thorac Cardiovasc Surg 2007;55(5):310–2.
Beshay, M, Kaiser, H, Niedhart, D, Reymond, MA, Schmid, RA.Emphysema and secondary pneumothorax in young adults smoking cannabis. Eur J Cardiothorac Surg 2007;32(6):834–8.
Sadikot, RT, Greene, T, Meadows, K, Arnold, AG.Recurrence of primary spontaneous pneumothorax. Thorax 1997;52(9):805–9.
Wood, JR, Bellamy, D, Child, AH, Citron, KM.Pulmonary disease in patients with Marfan syndrome. Thorax 1984;39(10):780–4.
Bitar, ZI, Ahmed, S, Amin, AE, Jamal, K, Ridha, M.Prevalence of mitral valve prolapse in primary spontaneous pneumothorax. Prim Care Respir J 2006;15(6):342–5.
Robbesom, AA, Koenders, MM, Smits, NC, et al. Aberrant fibrillin-1 expression in early emphysematous human lung: a proposed predisposition for emphysema. Mod Pathol 2008;21(3):297–307.
Sugiyama, Y, Maeda, H, Yotsumoto, H, Takaku, F.Familial spontaneous pneumothorax. Thorax 1986;41(12):969–70.
Wright, J, Rossi, N, Skorton, D, et al. The metacarpal index in spontaneous pneumothorax. J Iowa Med Soc 1982;72(12):488–90.
Kawabata, Y, Watanabe, A, Yamaguchi, S, et al. Pleuropulmonary pathology of vascular Ehlers-Danlos syndrome: spontaneous laceration, haematoma and fibrous nodules. Histopathology 2010;56:944–550.
Noppen, M, Schramel, F.Pneumothorax. Eur Respir Mon 2002;22:279–96.
Argani, P, Askin, FB, Colombani, P, Perlman, EJ.Occult pulmonary synovial sarcoma confirmed by molecular techniques. Pediatr Dev Pathol 2000;3(1):87–90.
Gupta, D, Mishra, S, Faruqi, S, Aggarwal, AN.Aetiology and clinical profile of spontaneous pneumothorax in adults. Indian J Chest Dis Allied Sci 2006;48(4):261–4.
Hayashida, M, Seyama, K, Inoue, Y, Fujimoto, K, Kubo, K.The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors. Respirology 2007;12(4):523–30.
Steagall, WK, Glasgow, CG, Hathaway, OM, et al. Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis. Am J Physiol Lung Cell Mol Physiol 2007;293(3):L800–8.
Froudarakis, ME, Bouros, D, Voloudaki, A, et al. Pneumothorax as a first manifestation of sarcoidosis. Chest 1997;112(1):278–80.
Riley, EA.Boeck's sarcoid; a review based upon a clinical study of fifty-two cases. Am Rev Tuberc 1950;62(3):231–85.
Scadding, J.Sarcoidosis. London: Eyre and Spottiswood, 1967.
Alifano, M, Roth, T, Broet, SC, et al. Catamenial pneumothorax: a prospective study. Chest 2003;124(3):1004–8.
Augoulea, A, Lambrinoudaki, I, Christodoulakos, G.Thoracic endometriosis syndrome. Respiration 2008;75(1):113–9.
Baumann, MH, Noppen, M.Pneumothorax. Respirology 2004;9(2):157–64.
Ren, HZ, Zhu, CC, Yang, C, et al. Mutation analysis of the FLCN gene in Chinese patients with sporadic and familial isolated primary spontaneous pneumothorax. Clin Genet 2008;74(2):178–83.
Leter, EM, Koopmans, AK, Gille, JJ, van Os, TA, Vittoz, GG, David, EF, et al. Birt-Hogg-Dube syndrome: clinical and genetic studies of 20 families. J Invest Dermatol 2008;128(1):45–9.
Gunji, Y, Akiyoshi, T, Sato, T, et al. Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax. J Med Genet 2007;44(9):588–93.
Bense, L, Wiman, LG, Hedenstierna, G.Onset of symptoms in spontaneous pneumothorax: correlations to physical activity. Eur J Respir Dis 1987;71(3):181–6.
Sheard, JD, Taylor, W, Soorae, A, Pearson, MG.Pneumothorax and malignant mesothelioma in patients over the age of 40. Thorax 1991;46(8):584–5.
Askin, FB, McCann, BG, Kuhn, C.Reactive eosinophilic pleuritis: a lesion to be distinguished from pulmonary eosinophilic granuloma. Arch Pathol Lab Med 1977;101(4):187–91.
Jordan, KG, Kwong, JS, Flint, J, Muller, NL.Surgically treated pneumothorax. Radiologic and pathologic findings. Chest 1997;111(2):280–5.
Luna, E, Tomashefski, JF Jr, Brown, D, Clarke, RE, Kleinerman, J.Reactive eosinophilic pulmonary vascular infiltration in patients with spontaneous pneumothorax. Am J Surg Pathol 1994;18(2):195–9.
Fraire, A.Histopathology of pneumothorax: potential diagnostic pitfalls. Arch Pathol Lab Med 2007;131(6):848–9.
Cyr, PV, Vincic, L, Kay, JM.Pulmonary vasculopathy in idiopathic spontaneous pneumothorax in young subjects. Arch Pathol Lab Med 2000;124(5):717–20.
Butnor, KJ, Guinee, DG Jr.Pleuropulmonary pathology of Birt-Hogg-Dube syndrome. Am J Surg Pathol 2006;30(3):395–9.
Koga, S, Furuya, M, Takahashi, Y, et al. Lung cysts in Birt-Hogg-Dube syndrome: histopathological characteristics and aberrant sequence repeats. Pathol Int 2009;59(10):720–8.
Light, RW, Gary, Lee YC.Textbook of Pleural Diseases, 2nd ed. London: Hodder and Stoughton, 2008.
Anthonisen, NR.Regional lung function in spontaneous pneumothorax. Am Rev Respir Dis 1977;115(5):873–6.
Tomashefski, JF Jr, Dahms, B, Bruce, M.Pleura in pneumothorax. Comparison of patients with cystic fibrosis and idiopathic spontaneous pneumothorax. Arch Pathol Lab Med 1985;109(10):910–6.
Dunnill, MS.Metaplastic changes in the visceral pleura in a case of fibrocystic disease of the pancreas. J Pathol Bacteriol 1959;77(1):299–302.
Yokoi, T, Mark, EJ.Atypical mesothelial hyperplasia associated with bronchogenic carcinoma. Hum Pathol 1991;22(7):695–9.
Wilkinson, L, De, P, Bloxham, C.Mesothelial reaction in longstanding Crohn's ileitis simulating papillary mesothelioma. J Clin Pathol 2008;61(10):1119–21.
Venekamp, LN, Velkeniers, B, Noppen, M.Does ‘idiopathic pleuritis’ exist? Natural history of non-specific pleuritis diagnosed after thoracoscopy. Respiration 2005;72(1):74–8.
Sakuraba, M, Masuda, K, Hebisqwa, A, et al. Diagnostic value of thoracoscopic pleural biopsy for pleurisy under local anaesthesia. ANZ J Surg 2006;76(8):722–4.
Dressler, W.Idiopathic recurrent pericarditis; comparison with the postcommissurotomy syndrome; considerations of etiology and treatment. Am J Med 1955;18(4):591–601.
Dressler, W.The post-myocardial-infarction syndrome: a report on forty-four cases. AMA Arch Intern Med 1959;103(1):28–42.
Jerjes-Sanchez, C, Ibarra-Perez, C, Ramirez-Rivera, A, Padua-Gabriel, A, Gonzalez-Carmona, VM.Dressler-like syndrome after pulmonary embolism and infarction. Chest 1987;92(1):115–7.
Wessman, DE, Stafford, CM.The postcardiac injury syndrome: case report and review of the literature. South Med J 2006;99(3):309–14.
Kim, S, Sahn, SA.Postcardiac injury syndrome. An immunologic pleural fluid analysis. Chest 1996;109(2):570–2.
Bendjelid, K, Pugin, J.Is Dressler syndrome dead?Chest 2004;126(5):1680–2.
Ryu, JH, Sekiguchi, H, Yi, ES. Pulmonary manifestations of IgG4-related sclerosing disease. Eur Respir J. 2011 Jun 30.
Zen, Y, Inoue, D, Kitao, A, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2009;33(12):1886–93.
Yousem, SA.Pulmonary apical cap: a distinctive but poorly recognized lesion in pulmonary surgical pathology. Am J Surg Pathol 2001;25(5):679–83.
Yi, E, Aubry, MC.Pulmonary pseudoneoplasms. Arch Pathol Lab Med 2010;134(3):417–26.
Butler, C 2nd, Kleinerman, J.The pulmonary apical cap. Am J Pathol 1970;60(2):205–16.
Hillerdal, G.Pleural and parenchymal fibrosis mainly affecting the upper lung lobes in persons exposed to asbestos. Respir Med 1990;84(2):129–34.
McLoud, TC, Isler, RJ, Novelline, RA, et al. The apical cap. AJR Am J Roentgenol 1981;137(2):299–306.
Davson, J, Susman, W.Apical scars and their relationship to siliceous dust accumulation in non-silicotic lungs. J Pathol Bacteriol 1937;45:597–612.
Im, JG, Webb, WR, Han, MC, Park, JH.Apical opacity associated with pulmonary tuberculosis: high-resolution CT findings. Radiology 1991;178(3):727–31.
Reid, L.The connective tissue septa in the adult human lung. Thorax 1959;14:138–45.
Wood, D, Miller, A.The role of the dual pulmonary circulation in various pathologic conditions of the lungs. J Thorac Surg 1938;7:649–59.
Dail, DH.Pulmonary apical cap. Am J Surg Pathol 2001;25(10):1344.
Frankel, SK, Cool, CD, Lynch, DA, Brown, KK.Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004;126(6):2007–13.
Becker, CD, Gil, J, Padilla, ML.Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?Mod Pathol 2008;21(6):784–7.
Dacic, S, Colby, TV, Yousem, SA.Nodular amyloidoma and primary pulmonary lymphoma with amyloid production: a differential diagnostic problem. Mod Pathol 2000;13(9):934–40.
Kavuru, MS, Adamo, JP, Ahmad, M, Mehta, AC, Gephardt, GN.Amyloidosis and pleural disease. Chest 1990;98(1):20–3.
Xu, L, Cai, BQ, Zhong, X, Zhu, YJ.Respiratory manifestations in amyloidosis. Chin Med J (Engl) 2005;118(24):2027–33.
Bontemps, F, Tillie-Leblond, I, Coppin, MC, et al. Pleural amyloidosis: thoracoscopic aspects. Eur Respir J 1995;8(6):1025–7.
Graham, DD, McGahren, ED, Tribble, CG, Daniel, TM, Rodgers, BM.Use of video-assisted thoracic surgery in the treatment of chylothorax. Ann Thorac Surg 1994;57(6):1507–11; discussion 11–2.
Berk, JL, Keane, J, Seldin, DC, et al. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest 2003;124(3):969–77.
Roux, CH, Breuil, V, Brocq, O, Euller-Ziegler, L.Pleural amyloidosis as the first sign of IgD multiple myeloma. Clin Rheumatol 2005;24(3):294–5.
Smith, FB, Brown, RB, Maguire, G, Oliver, J.Localized pleural microdeposition of type A amyloid in a patient with rheumatoid pleuritis. Histologic distinction from pleural involvement in systemic amyloidosis. Am J Clin Pathol 1993;99(3):261–4.
Leleu, O, Clarot, C, Renaud, H, et al. [Amyloidosis and pleural calcification]. Rev Mal Respir 2003;20(4):618–21.
Adams, AL, Castro, CY, Singh, SP, Moran, CA.Pleural amyloidosis mimicking mesothelioma: a clinicopathologic study of two cases. Ann Diagn Pathol 2001;5(4):229–32.
Seibert, AF, Haynes, J Jr, Middleton, R, Bass, JB Jr.Tuberculous pleural effusion. Twenty-year experience. Chest 1991;99(4):883–6.
Chakrabarti, B, Davies, PD.Pleural tuberculosis. Monaldi Arch Chest Dis 2006;65(1):26–33.
Malhotra, P, Aggarwal, AN, Agarwal, R, et al. Clinical characteristics and outcomes of empyema thoracis in 117 patients: a comparative analysis of tuberculous vs. non-tuberculous aetiologies. Respir Med 2007;101(3):423–30.
Bourkadi, JE, Benjelloun, MC, Amara, B, et al. [Pleurisy and sarcoidosis. Apropos of 2 cases]. Rev Pneumol Clin 2000;56(5):325–8.
Sugino, K, Kimura, K, Hiroi, M, et al. [A case of pleural sarcoidosis in which vats lung biopsy, obtained pleural and pulmonary lesions]. Nihon Kokyuki Gakkai Zasshi 2006;44(11):838–43.
Abarquez, C, Sharma, OP.An unusual presentation of sarcoidosis in a Korean woman. Sarcoidosis 1989;6(2):153–5.
Miyaji, A, Konno, H, Yamazaki, M, Ohwada, A.[A patient with pleural thickening of sarcoidosis]. Nihon Kokyuki Gakkai Zasshi 2005;43(5):308–12.
Tommasini, A, Di Vittorio, G, Facchinetti, F, et al. Pleural effusion in sarcoidosis: a case report. Sarcoidosis 1994;11(2):138–40.
Watarai, M, Yazawa, M, Yamanda, K, Yamamoto, H, Yamazaki, Y.Pulmonary sarcoidosis with associated bloody pleurisy. Intern Med 2002;41(11):1021–3.
Chittock, DR, Joseph, MG, Paterson, NA, McFadden, RG.Necrotizing sarcoid granulomatosis with pleural involvement. Clinical and radiographic features. Chest 1994;106(3):672–6.
Parkes, WR.Occupational Lung Disorders, 3rd ed. Oxford: Butterworth- Heineman, 1994.
Weir, IH, Muller, NL, Chiles, C, et al. Wegener's granulomatosis: findings from computed tomography of the chest in 10 patients. Can Assoc Radiol J 1992;43(1):31–4.
Storelli, E, Casali, C, Natali, P, Rossi, G, Morandi, U.Unusual pathogenesis of spontaneous pneumothorax secondary to Wegener's granulomatosis. Ann Thorac Surg 2007;84(1):288–90.
Galateau, F, Loire, R, Capron, F, et al. [Pulmonary lesions in Wegener's disease. Report of the French Anatomo-clinical Research Group. Study of 40 pulmonary biopsies]. Rev Mal Respir 1992;9(4):431–42.
Faratian, D, Marr, LD, Bollert, F, et al. Pleural Wegener's granulomatosis: a rare presentation. Histopathology 2009;54:391–3.
Godman, GC, Churg, J.Wegener's granulomatosis: pathology and review of the literature. AMA Arch Pathol 1954;58(6):533–53.
Remiszewski, P, Gawryluk, D, Podsiadlo, B, et al. [Invasive aspergillosis (IA) in patients treated in the Institute of Tuberculosis and Chest Diseases in the years 1993–2005 – diagnostic problems]. Pneumonol Alergol Pol 2006;74(2):197–202.
Kawabata, T, Matsuyama, W, Higashimoto, I, et al. Pleural cryptococcosis with idiopathic CD4 positive T-lymphocytopenia. Intern Med 2004;43(10):977–81.
Saarinen, KA, Lestringant, GG, Czechowski, J, Frossard, PM.Cutaneous nocardiosis of the chest wall and pleura – 10-year consequences of a hand actinomycetoma. Dermatology 2001;202(2):131–3.
Sundar, K, Rosado-Santos, H, Reimer, L, Murray, K, Michael, J.Unusual presentation of thoracic Pneumocystis carinii infection in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 2001;32(3):498–501.
Wiesman, IM, Podbielski, FJ, Hernan, MJ, Sekosan, M, Vigneswaran, WT.Thoracic blastomycosis and empyema. JSLS 1999;3(1):75–8.
Furst, SR, Weinger, MB, Simons, SM.Pleuropulmonary amebiasis. Chest 1991;100:293.
Shamsuzzaman, SM, Hashiguchi, Y.Thoracic amebiasis. Clin Chest Med 2002;23(2):479–92.
Mizutani, E, Morita, R, Hanaoka, S, et al. Pleuropulmonary paragonimiasis with intrathoracic mass. Ann Thorac Cardiovasc Surg 2010;16(6):436–8.
Sharma, N, Mahomed, MF, Bhatnagar, A, Kumar, P, Mantoo, SK.Simultaneous filarial infection of the pleura and breast. S Afr Med J 2007;97(10):896–8.
Sakamoto, T, Gutierrez, C.Pulmonary complications of cystic echinococcosis in children in Uruguay. Pathol Int 2005;55(8):497–503.
Milanez de Campos, JR, Barbas, CS, et al. Human pulmonary dirofilariasis: analysis of 24 cases from Sao Paulo, Brazil. Chest 1997;112(3):729–33.
Guardia, SN, Sepp, H, Scholten, T, Morava-Protzner, I.Pentastomiasis in Canada. Arch Pathol Lab Med 1991;115(5):515–7.
Bouros, D, Pneumatikos, I, Tzouvelekis, A.Pleural involvement in systemic autoimmune disorders. Respiration 2008;75(4):361–71.
Maeshima, E, Nishimoto, T, Yamashita, M, Mune, M, Yukawa, S.Progressive systemic sclerosis-polymyositis overlap syndrome with eosinophilic pleural effusion. Rheumatol Int 2003;23(5):252–4.
Hunninghake, GW, Fauci, AS.Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 1979;119(3):471–503.
Carr, DT, Power, MH.Pleural fluid glucose with special reference to its concentration in rheumatoid pleurisy with effusion. Dis Chest 1960;37:321–4.
Aru, A, Engel, U, Francis, D.Characteristic and specific histological findings in rheumatoid pleurisy. Acta Pathol Microbiol Immunol Scand [A] 1986;94(1):57–62.
Pleural effusion in rheumatoid arthritis. Lancet 1972;1(7748):480–1.
Faurschou, P.Thoracoscopy in rheumatoid pleural effusion. Pneumologie 1989;43(2):69–71.
Martel, W, Abell, MR, Mikkelsen, WM, Whitehouse, WM.Pulmonary and pleural lesions in rheumatoid disease. Radiology 1968;90(4):641–53.
Brown, KK.Rheumatoid lung disease. Proc Am Thorac Soc 2007;4(5):443–8.
Purnell, DC, Baggenstoss, AH, Olsen, AM.Pulmonary lesions in disseminated lupus erythematosus. Ann Intern Med 1955;42(3):619–28.
Cohen, AS, Canoso, JJ.Criteria for the classification of systemic lupus erythematosus – status 1972. Arthritis Rheum 1972;15(5):540–3.
Pines, A, Kaplinsky, N, Olchovsky, D, Rozenman, J, Frankl, O.Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications. Chest 1985;88(1):129–35.
Gross, M, Esterly, JR, Earle, RH.Pulmonary alterations in systemic lupus erythematosus. Am Rev Respir Dis 1972;105(4):572–7.
Haupt, HM, Moore, GW, Hutchins, GM.The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 1981;71(5):791–8.
Miller, LR, Greenberg, SD, McLarty, JW.Lupus lung. Chest 1985;88(2):265–9.
Ropes, MW.Observations on the natural course of disseminated lupus erythematosus. Medicine (Baltimore) 1964;43:387–91.
English, JC, Leslie, KO.Pathology of the pleura. Clin Chest Med 2006;27(2):157–80.
Good, JT Jr, King, TE, Antony, VB, Sahn, SA.Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 1983;84(6):714–8.
Huggins, JT, Sahn, SA.Drug-induced pleural disease. Clin Chest Med 2004;25(1):141–53.
Antony, VB.Drug-induced pleural disease. Clin Chest Med 1998;19(2):331–40.
Diri, E, Tello, W, Ratnoff, WD, Nugent, K.Infliximab-induced SLE-like syndrome involving the lung and pleura. Lupus 2007;16(9):764–6.
Sarzi-Puttini, P, Atzeni, F, Capsoni, F, Lubrano, E, Doria, A.Drug-induced lupus erythematosus. Autoimmunity 2005;38(7):507–18.
Yung, RL, Richardson, BC.Drug-induced lupus. Rheum Dis Clin North Am 1994;20(1):61–86.
Baram, A, Bagan, P, Danel, C, Badia, A, Riquet M. [Pleural endometriosis: an unusual presentation]. Rev Mal Respir 2005;22(4):677–80.
Flieder, DB, Moran, CA, Travis, WD, Koss, MN, Mark, EJ.Pleuro-pulmonary endometriosis and pulmonary ectopic deciduosis: a clinicopathologic and immunohistochemical study of 10 cases with emphasis on diagnostic pitfalls. Hum Pathol 1998;29(12):1495–503.
Alifano, M, Cancellieri, A, Fornelli, A, Trisolini, R, Boaron, M.Endometriosis-related pneumothorax: clinicopathologic observations from a newly diagnosed case. J Thorac Cardiovasc Surg 2004;127(4):1219–21.
Morcos, M, Alifano, M, Gompel, A, Regnard, JF.Life-threatening endometriosis-related hemopneumothorax. Ann Thorac Surg 2006;82(2):726–9.
Dhanaworavibul, K, Hanprasertpong, J, Cheewadhanaraks, S, Buhachat, R.Bilateral pleural endometriosis. J Obstet Gynaecol Res 2006;32(1):86–9.
Tsunezuka, Y, Oda, M, Moriyama, H, Ohshima, M, Kurumaya, H.Thoracoscopic findings and surgical management of catamenial hemopneumothorax. Ann Thorac Cardiovasc Surg 2006;12(3):197–9.
Zaatari, GS, Gupta, PK, Bhagavan, BS, Jarboe, BR.Cytopathology of pleural endometriosis. Acta Cytol 1982;26(2):227–32.
Nair, SK, Petko, M, Hayward, MP.Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surg 2007;32(2):362–9.
Pfleger, A, Schwinger, W, Maier, A, et al. Gorham-Stout syndrome in a male adolescent-case report and review of the literature. J Pediatr Hematol Oncol 2006;28(4):231–3.
Urban, T, Lazor, R, Lacronique, J, Murris, M, Labrune, S, Valeyre, D, et al. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P). Medicine (Baltimore) 1999;78(5):321–37.
Emerson, PA.Yellow nails, lymphoedema, and pleural effusions. Thorax 1966;21(3):247–53.
Agrawal, V, Sahn, SA.Lipid pleural effusions. Am J Med Sci 2008;335(1):16–20.
Pinkard, NB, Wilson, RW, Lawless, N, et al. Calcifying fibrous pseudotumor of pleura. A report of three cases of a newly described entity involving the pleura. Am J Clin Pathol 1996;105(2):189–94.
Suh, JH, Shin, OR, Kim, YH.Multiple calcifying fibrous pseudotumor of the pleura. J Thorac Oncol 2008;3(11):1356–8.
Shibata, K, Yuki, D, Sakata, K.Multiple calcifying fibrous pseudotumors disseminated in the pleura. Ann Thorac Surg 2008;85(2):e3–5.
Bobbio, A, Mazzeo, A, Carbognani, P, Rusca, M.An unusual case of calcifying fibrous pseudotumour of the cervicothoracic junction. Eur J Cardiothorac Surg 2008;34(5):1123–5.
Kawahara, K, Yasukawa, M, Nakagawa, K, et al. Multiple calcifying fibrous tumor of the pleura. Virchows Arch 2005;447(6):1007–8.
Mito, K, Kashima, K, Daa, T, et al. Multiple calcifying fibrous tumors of the pleura. Virchows Arch 2005;446(1):78–81.
Chen, KT.Familial peritoneal multifocal calcifying fibrous tumor. Am J Clin Pathol 2003;119(6):811–5.
Hainaut, P, Lesage, V, Weynand, B, Coche, E, Noirhomme, P.Calcifying fibrous pseudotumor (CFPT): a patient presenting with multiple pleural lesions. Acta Clin Belg 1999;54(3):162–4.
Sudhakar, S, Mistry, Y, Dastidar, A, Sen, S, Gibikote, S.Calcifying fibrous tumour: an unusual omental lesion. Pediatr Radiol 2008;38(11):1246–8.
Emanuel, P, Qin, L, Harpaz, N.Calcifying fibrous tumor of small intestine. Ann Diagn Pathol 2008;12(2):138–41.
Dargent, JL, Delplace, J, Roufosse, C, Laget, JP, Lespagnard, L.Development of a calcifying fibrous pseudotumour within a lesion of Castleman disease, hyaline-vascular subtype. J Clin Pathol 1999;52(7):547–9.
Nascimento, AF, Ruiz, R, Hornick, JL, Fletcher, CD.Calcifying fibrous ‘pseudotumor’: clinicopathologic study of 15 cases and analysis of its relationship to inflammatory myofibroblastic tumor. Int J Surg Pathol 2002;10(3):189–96.
Jang, KS, Oh, YH, Han, HX, et al. Calcifying fibrous pseudotumor of the pleura. Ann Thorac Surg 2004;78(6):e87–8.
Hill, KA, Gonzalez-Crussi, F, Chou, PM.Calcifying fibrous pseudotumor versus inflammatory myofibroblastic tumor: a histological and immunohistochemical comparison. Mod Pathol 2001;14(8):784–90.
Sigel, JE, Smith, TA, Reith, JD, Goldblum, JR.Immunohistochemical analysis of anaplastic lymphoma kinase expression in deep soft tissue calcifying fibrous pseudotumor: evidence of a late sclerosing stage of inflammatory myofibroblastic tumor?Ann Diagn Pathol 2001;5(1):10–4.
Weynand, B, Draguet, AP, Bernard, P, Marbaix, E, Galant, C.Calcifying fibrous pseudotumour: first case report in the peritoneum with immunostaining for CD34. Histopathology 1999;34(1):86–7.
England, DM, Hochholzer, L, McCarthy, MJ.Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 1989;13(8):640–58.
Travis, WD, Brambilla, E, Müller-Hermelink, HK, Harris, CC.Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC, 2004.
Fletcher, CDM, Unni, KK, Mertens, F, eds. Tumours of Soft Tissue and Bone. Lyon: IARC, 2002.
Balduyck, B, Lauwers, P, Govaert, K, et al. Solitary fibrous tumor of the pleura with associated hypoglycemia: Doege-Potter syndrome: a case report. J Thorac Oncol 2006;1(6):588–90.
Eguchi, T, Ito, N, Makiuchi, A, Yoshida, K.A solitary fibrous tumor arising from the thymus. Interact Cardiovasc Thorac Surg 2010;11(3):362–3.
Larsen, SR, Godballe, C, Krogdahl, A.Solitary fibrous tumor arising in an intrathoracic goiter. Thyroid 2010;20(4):435–7.
Okike, N, Bernatz, PE, Woolner, LB.Localized mesothelioma of the pleura: benign and malignant variants. J Thorac Cardiovasc Surg 1978;75(3):363–72.
Thorgeirsson, T, Isaksson, HJ, Hardardottir, H, Alfredsson, H, Gudbjartsson, T.Solitary fibrous tumors of the pleura: an estimation of population incidence. Chest 2010;137(4):1005–6.
Klemperer, P, Rabin, CB.Primary neoplasms of the pleura: a report of 5 cases. Arch Pathol 1931;11:385–41.
Hernandez, FJ, Fernandez, BB.Localized fibrous tumors of pleura: a light and electron microscopic study. Cancer 1974;34(5):1667–74.
van de Rijn, M, Lombard, CM, Rouse, RV.Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung. Am J Surg Pathol 1994;18(8):814–20.
Gengler, C, Guillou, L.Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology 2006;48(1):63–74.
Mertens, F, Willen, R, Lillo-Gil, R, Mitelman, F, Mandahl, N.Translocation (2;3)(p21;p26) as the sole anomaly in a benign localized fibrous mesothelioma. Cancer Genet Cytogenet 1996;92(1):90–1.
Horton, ES, Dobin, SM, Donner, LR.A clonal t(8;12)(p11.2;q24.3) as the sole abnormality in a solitary fibrous tumor of the pleura. Cancer Genet Cytogenet 2007;172(1):77–9.
de Leval, L, Defraigne, JO, Hermans, G, et al. Malignant solitary fibrous tumor of the pleura: report of a case with cytogenetic analysis. Virchows Arch 2003;442(4):388–92.
Donner, LR, Silva, MT, Dobin, SM.Solitary fibrous tumor of the pleura: a cytogenetic study. Cancer Genet Cytogenet 1999;111(2):169–71.
Miettinen, MM, el-Rifai, W, Sarlomo-Rikala, M, Andersson, LC, Knuutila, S.Tumor size-related DNA copy number changes occur in solitary fibrous tumors but not in hemangiopericytomas. Mod Pathol 1997;10(12):1194–200.
Rosado-de-Christenson, ML, Abbott, GF, McAdams, HP, Franks, TJ, Galvin, JR.From the archives of the AFIP: Localized fibrous tumor of the pleura. Radiographics 2003;23(3):759–83.
Okuda, M, Yokomise, H, Chang, SS, Nakano, J, Misaki, N.Solitary fibrous tumor of the pleura presenting dry cough induced by postural position. Ann Thorac Cardiovasc Surg 2009;15(6):401–3.
Cardillo, G, Facciolo, F, Cavazzana, AO, et al. Localized (solitary) fibrous tumors of the pleura: an analysis of 55 patients. Ann Thorac Surg 2000;70(6):1808–12.
Zhang, H, Lucas, DR, Pass, HI, Che, M.Disseminated malignant solitary fibrous tumor of the pleura. Pathol Int 2004;54(2):111–5.
Fujiu, K, Miyamoto, H, Sakuma, H, Mori, M.Solitary fibrous tumors of the pleura presenting satellite tumors. Gen Thorac Cardiovasc Surg 2009;57(7):382–4.
Kalebi, AY, Hale, MJ, Wong, ML, Hoffman, T, Murray, J.Surgically cured hypoglycemia secondary to pleural solitary fibrous tumour: case report and update review on the Doege-Potter syndrome. J Cardiothorac Surg 2009;4:45.
Sergew, A, Merrick, D, Chan, ED.A 64-year-old man with joint swelling and an abnormal chest radiograph. Chest 2008;133(3):805–8.
Cazaban, S, Icard, P, Le Rochais, JP, et al. [Pleural fibromas: a review based on 12 cases]. Ann Chir 1999;53(3):215–21.
Hojo, S, Fujita, J, Yamadori, I, et al. Hepatocyte growth factor and digital clubbing. Intern Med 1997 Jan;36(1):44–6.
Sawada, N, Ishiwata, T, Naito, Z, et al. Immunohistochemical localization of endothelial cell markers in solitary fibrous tumor. Pathol Int 2002;52(12):769–76.
De Pas, T, Toffalorio, F, Colombo, P, et al. Brief report: activity of imatinib in a patient with platelet-derived-growth-factor receptor positive malignant solitary fibrous tumor of the pleura. J Thorac Oncol 2008;3(8):938–41.
Briselli, M, Mark, EJ, Dickersin, GR.Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature. Cancer 1981;47(11):2678–89.
Steigen, SE, Schaeffer, DF, West, RB, Nielsen, TO.Expression of insulin-like growth factor 2 in mesenchymal neoplasms. Mod Pathol 2009;22(7):914–21.
Song, SW, Jung, JI, Lee, KY, Kim, MY, Park, SH.Malignant solitary fibrous tumor of the pleura: computed tomography-pathological correlation and comparison with computed tomography of benign solitary fibrous tumor of the pleura. Jpn J Radiol 2010;28(8):602–8.
Ordonez, NG.Localized (solitary) fibrous tumor of the pleura. Adv Anat Pathol 2000;7(6):327–40.
de Perrot, M, Fischer, S, Brundler, MA, Sekine, Y, Keshavjee, S.Solitary fibrous tumors of the pleura. Ann Thorac Surg 2002;74(1):285–93.
Watts, DM, Jones, GP, Bowman, GA, Olsen, JD.Giant benign mesothelioma. Ann Thorac Surg 1989;48(4):590–1.
Suter, M, Gebhard, S, Boumghar, M, Peloponisios, N, Genton, CY.Localized fibrous tumours of the pleura: 15 new cases and review of the literature. Eur J Cardiothorac Surg 1998;14(5):453–9.
de Saint, AubainSomerhausen, N, Rubin, BP, Fletcher, CD.Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differential diagnosis. Mod Pathol 1999;12(5):463–71.
Schirosi, L, Lantuejoul, S, Cavazza, A, et al. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR. Am J Surg Pathol 2008;32(11):1627–42.
Mosquera, JM, Fletcher, CD.Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component – is this dedifferentiated SFT?Am J Surg Pathol 2009;33(9):1314–21.
Sung, SH, Chang, JW, Kim, J, et al. Solitary fibrous tumors of the pleura: surgical outcome and clinical course. Ann Thorac Surg 2005;79(1):303–7.
Ali, SZ, Hoon, V, Hoda, S, Heelan, R, Zakowski, MF.Solitary fibrous tumor. A cytologic-histologic study with clinical, radiologic, and immunohistochemical correlations. Cancer 1997;81(2):116–21.
Cavazza, A, Rossi, G, Agostini, L, et al. Cytokeratin-positive malignant solitary fibrous tumour of the pleura: an unusual pitfall in the diagnosis of pleural spindle cell neoplasms. Histopathology 2003;43(6):606–8.
Yan, B, Raju, GC, Salto-Tellez, M.Epithelioid, cytokeratin expressing malignant solitary fibrous tumour of the pleura. Pathology 2008;40(1):98–9.
Yokoi, T, Tsuzuki, T, Yatabe, Y, et al. Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformation. Histopathology 1998;32(5):423–32.
el-Naggar, AK, Ro, JY, Ayala, AG, Ward, R, Ordonez, NG.Localized fibrous tumor of the serosal cavities. Immunohistochemical, electron-microscopic, and flow-cytometric DNA study. Am J Clin Pathol 1989;92(5):561–5.
Ide, F, Obara, K, Mishima, K, Saito, I, Kusama, K.Ultrastructural spectrum of solitary fibrous tumor: a unique perivascular tumor with alternative lines of differentiation. Virchows Arch 2005;446(6):646–52.
Rodriguez-Gil, Y, Gonzalez, MA, Carcavilla, CB, Santamaria, JS.Lines of cell differentiation in solitary fibrous tumor: an ultrastructural and immunohistochemical study of 10 cases. Ultrastruct Pathol 2009;33(6):274–85.
Rossi, G, Schirosi, L, Giovanardi, F, Sartori, G, Paci, M, Cavazza, A.Pleural malignant solitary fibrous tumor with sarcomatous overgrowth showing PDGFRbeta mutation. Chest 2006;130(2):581–3.
Liu, CC, Wang, HW, Li, FY, et al. Solitary fibrous tumors of the pleura: clinicopathological characteristics, immunohistochemical profiles, and surgical outcomes with long-term follow-up. Thorac Cardiovasc Surg 2008;56(5):291–7.
Allen, TC, Cagle, PT, Churg, AM, et al. Localized malignant mesothelioma. Am J Surg Pathol 2005;29(7):866–73.
Naito, Y, Ishii, G, Kawai, O, et al. D2–40-positive solitary fibrous tumors of the pleura: diagnostic pitfall of biopsy specimen. Pathol Int 2007;57(9):618–21.
Aubry, MC, Bridge, JA, Wickert, R, Tazelaar, HD.Primary monophasic synovial sarcoma of the pleura: five cases confirmed by the presence of SYT-SSX fusion transcript. Am J Surg Pathol 2001;25(6):776–81.
Argani, P, Zakowski, MF, Klimstra, DS, Rosai, J, Ladanyi, M.Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. Mod Pathol 1998;11(1):65–71.
Benchetritt, M, Hofman, V, Venissac, N, et al. Dedifferentiated liposarcoma of the pleura mimicking a malignant solitary fibrous tumor and associated with dedifferentiated liposarcoma of the mediastinum: usefulness of cytogenetic and molecular genetic analyses. Cancer Genet Cytogenet 2007;179(2):150–5.
Andino, L, Cagle, PT, Murer, B, et al. Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fibrous tumors and assessment of beta-catenin and cyclin D1 expression. Arch Pathol Lab Med 2006;130(10):1503–9.
Shidham, VB, Chivukula, M, Gupta, D, Rao, RN, Komorowski, R.Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor. Arch Pathol Lab Med 2002;126(10):1189–92.
Butnor, KJ, Burchette, JL, Sporn, TA, Hammar, SP, Roggli, VL.The spectrum of Kit (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single-source antibody with a review of the literature. Arch Pathol Lab Med 2004;128(5):538–43.
Pintelon, I, Brouns, I, De Proost, I, et al. Sensory receptors in the visceral pleura: neurochemical coding and live staining in whole mounts. Am J Respir Cell Mol Biol 2007;36(5):541–51.
Khan, JH, Rahman, SB, Clary-Macy, C, et al. Giant solitary fibrous tumor of the pleura. Ann Thorac Surg 1998;65(5):1461–4.
Cardillo, G, Carbone, L, Carleo, F, et al. Solitary fibrous tumors of the pleura: an analysis of 110 patients treated in a single institution. Ann Thorac Surg 2009;88(5):1632–7.
Leuenberger, P.[Cough: physiology and pathophysiology]. Schweiz Med Wochenschr 1988;118(25):955–9.
McCool, FD, Leith, DE.Pathophysiology of cough. Clin Chest Med 1987;8(2):189–95.
Robinson, LA.Solitary fibrous tumor of the pleura. Cancer Control 2006;13(4):264–9.
Hoffmann, H, Giger, OT, Bubendorf, L, Lardinois, D.Contralateral recurrence of a malignant solitary fibrous tumor of the pleura. Interact Cardiovasc Thorac Surg 2011;12(2):306–7.
Harrison-Phipps, KM, Nichols, FC, Schleck, CD, et al. Solitary fibrous tumors of the pleura: results of surgical treatment and long-term prognosis. J Thorac Cardiovasc Surg 2009;138(1):19–25.
Cottin, V, Brillet, PY, Combarnous, F, et al. Syndrome of pleural and retrosternal “bridging” fibrosis and retroperitoneal fibrosis in patients with asbestos exposure. Thorax 2008;63(2):177–9.
Sauni, R, Oksa, P, Jarvenpaa, R, Parker, JE, Roto, P.Asbestos exposure: a potential cause of retroperitoneal fibrosis. Am J Ind Med 1998;33(4):418–21.
Davies, D, Andrews, MI, Jones, JS.Asbestos induced pericardial effusion and constrictive pericarditis. Thorax 1991;46(6):429–32.
Korhola, O, Hiltunen, A, Karjalainen, A, Martikainen, R, Riihimaki, H.Association between pleural plaques and coronary heart disease. Scand J Work Environ Health 2001;27(2):154–5.
Sanden, A, Jarvholm, B, Larsson, S.The importance of lung function, non-malignant diseases associated with asbestos, and symptoms as predictors of ischaemic heart disease in shipyard workers exposed to asbestos. Br J Ind Med 1993;50(9):785–90.
Harding, AH, Darnton, A, Wegerdt, J, McElvenny, D.Mortality among British asbestos workers undergoing regular medical examinations (1971–2005). Occup Environ Med 2009;66(7):487–95.
Sjogren, B.Mortality among British asbestos workers. Occup Environ Med 2009;66(12):854–5.
Hillerdal, G.The human evidence: parenchymal and pleural changes. Ann Occup Hyg 1994;38(4):561–7, 417.
Segarra, F, Monte, MB, Ibanez, PL, Gonzalez, AG, Nicolas, JP.Asbestosis in the industries of the Barcelona area. Am J Ind Med 1980;1(2):149–58.
Koskinen, K, Zitting, A, Tossavainen, A, et al. Radiographic abnormalities among Finnish construction, shipyard and asbestos industry workers. Scand J Work Environ Health 1998;24(2):109–17.
Rossiter, CE, Browne, K, Gilson, JC.International classification trial of AIA set of 100 radiographs of asbestos workers. Br J Ind Med 1988;45(8):538–43.
Gevenois, PA, De Vuyst, P, Dedeire, S, et al. Conventional and high-resolution CT in asymptomatic asbestos-exposed workers. Acta Radiol 1994;35(3):226–9.
Ochsmann, E, Carl, T, Brand, P, Raithel, HJ, Kraus, T.Inter-reader variability in chest radiography and HRCT for the early detection of asbestos-related lung and pleural abnormalities in a cohort of 636 asbestos-exposed subjects. Int Arch Occup Environ Health 2010;83(1):39–46.
Paris, C, Thierry, S, Brochard, P, et al. Pleural plaques and asbestosis: dose- and time-response relationships based on HRCT data. Eur Respir J 2009;34(1):72–9.
Boutin, C, Dumortier, P, Rey, F, Viallat, JR, De Vuyst, P.Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study. Am J Respir Crit Care Med 1996;153(1):444–9.
Sheers, G, Templeton, AR.Effects of asbestos in dockyard workers. Br Med J 1968;3:574–9.
Paris, C, Martin, A, Letourneux, M, Wild, P.Modelling prevalence and incidence of fibrosis and pleural plaques in asbestos-exposed populations for screening and follow-up: a cross-sectional study. Environ Health 2008;7:30.
Mollo, F, Andrion, A, Pira, E, Barocelli, MP.Indicators of asbestos exposure in autopsy routine. 2. Pleural plaques and occupation. Med Lav 1983;74(2):137–42.
Artvinli, M, Baris, YI.Environmental fiber-induced pleuro-pulmonary diseases in an Anatolian village: an epidemiologic study. Arch Environ Health 1982;37(3):177–81.
Ates, G, Yildiz, T, Akyildiz, L, Topcu, F, Erturk, B.Environmental asbestos-related pleural plaque in southeast of Turkey. Arch Environ Occup Health 2010 Jan-Mar 1;65(1):34–7.
Boutin, G, Viallat, JR, Steinbauer, J, Dufour, G, Gaudichet, A.Bilateral pleural plaques in Corsica: a marker of non-occupational asbestos exposure. IARC Sci Publ 1989(90):406–10.
Manda-Stachouli, C, Dalavanga, Y, Daskalopoulos, G, et al. Decreasing prevalence of pleural calcifications among Metsovites with nonoccupational asbestos exposure. Chest 2004;126(2):617–21.
Churg, A, DePaoli, L.Environmental pleural plaques in residents of a Quebec chrysotile mining town. Chest 1988;94(1):58–60.
Rom, WN, Hammar, SP, Rusch, V, Dodson, R, Hoffman, S.Malignant mesothelioma from neighborhood exposure to anthophyllite asbestos. Am J Ind Med 2001;40(2):211–4.
Tossavainen, A, Huuskonen, MS.A national program to reduce the risk of asbestos-related disease in Finland. In Banks, DE, Parker, JE, eds. Occupational Lung Disease: An International Perspective. London: Chapman and Hall Medical, 1998.
Karjalainen, A, Karhunen, PJ, Lalu, K, et al. Pleural plaques and exposure to mineral fibres in a male urban necropsy population. Occup Environ Med 1994;51(7):456–60.
Davis, JM, Gylseth, B, Morgan, A.Assessment of mineral fibres from human lung tissue. Thorax 1986;41(3):167–75.
Kogan, FM.Asbestos-related diseases in Russia. In Banks, DE, Parker, JE, eds. Occupational Lung Disease: An International Perspective. London: Chapman and Hall Medical, 1998.
Dave, SK, Beckett, WS.Occupational asbestos exposure and predictable asbestos-related diseases in India. Am J Ind Med 2005;48(2):137–43.
Luo, S, Liu, X, Mu, S, Tsai, SP, Wen, CP.Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data. Occup Environ Med 2003;60(1):35–41; discussion -2.
Liu, XZ, Luo, SQ, Wang, ZM, Wang, MZ, Zhan, CL.An investigation of crocidolite contamination and mesothelioma in a rural area of China. Biomed Environ Sci 1990;3(2):156–65.
Cai, SX, Zhang, CH, Zhang, X, Morinaga, K.Epidemiology of occupational asbestos-related diseases in China. Ind Health 2001;39(2):75–83.
Hiraoka, T, Ando, M, Shima, K, et al. [Epidemiologic survey of pleural plaques among inhabitants of Matsubase exposed to asbestos]. Nihon Kyobu Shikkan Gakkai Zasshi 1996;34(4):385–91.
Hourihane, DOB, Lessof, L, Richardson, PC.Hyaline and calcified pleural plaques as an index for exposure to asbestos: a study of radiological and pathological features of 100 cases with a consideration of epidemiology. Brit Med J 1966;1:1069–74.
Andrion, A, Colombo, A, Dacorsi, M, Mollo, F.Pleural plaques at autopsy in Turin: a study on 1,019 adult subjects. Eur J Respir Dis 1982;63(2):107–12.
Kohyama, N, Suzuki, Y.Analysis of asbestos fibers in lung parenchyma, pleural plaques, and mesothelioma tissues of North American insulation workers. Ann N Y Acad Sci 1991;643:27–52.
Oury, TD, ed. Benign Asbestos-Related Pleural Disease, 2nd ed. New York: Springer, 2004.
Sichletidis, L, Spyratos, D, Chloros, D, Michailidis, K, Fourkiotou, I.Pleural plaques in dentists from occupational asbestos exposure: a report of three cases. Am J Ind Med 2009;52(12):926–30.
Scancarello, G, Romeo, R, Sartorelli, E.Respiratory disease as a result of talc inhalation. J Occup Environ Med 1996;38(6):610–4.
Merchant, JA.Human epidemiology: a review of fiber type and characteristics in the development of malignant and nonmalignant disease. Environ Health Perspect 1990;88:287–93.
Chaudhary, BA, Kanes, GJ, Pool, WH.Pleural thickening in mild kaolinosis. South Med J 1997;90(11):1106–9.
Brown, RC, Bellmann, B, Muhle, H, Davis, JM, Maxim, LD.Survey of the biological effects of refractory ceramic fibres: overload and its possible consequences. Ann Occup Hyg 2005;49(4):295–307.
Lockey, J, Lemasters, G, Rice, C, et al. Refractory ceramic fiber exposure and pleural plaques. Am J Respir Crit Care Med 1996;154(5):1405–10.
Glass, LR, Brown, RC, Hoskins, JA.Health effects of refractory ceramic fibres: scientific issues and policy considerations. Occup Environ Med 1995;52(7):433–40.
Garabrant, DH, Fine, LJ, Oliver, C, Bernstein, L, Peters, JM.Abnormalities of pulmonary function and pleural disease among titanium metal production workers. Scand J Work Environ Health 1987;13(1):47–51.
Chen, JL, Fayerweather, WE.Epidemiologic study of workers exposed to titanium dioxide. J Occup Med 1988;30(12):937–42.
Fayerweather, WE, Karns, ME, Gilby, PG, Chen, JL.Epidemiologic study of lung cancer mortality in workers exposed to titanium tetrachloride. J Occup Med 1992;34(2):164–9.
Langer, AM, Nolan, RP.Asbestos disease in foundrymen. J Occup Environ Med 1997;39(8):699–700.
Rous, V, Studeny, J.Aetiology of pleural plaques. Thorax 1970;25(3):270–84.
Andrion, A, Pira, E, Mollo, F.Pleural plaques at autopsy, smoking habits, and asbestos exposure. Eur J Respir Dis 1984;65(2):125–30.
McMillan, GH, Pethybridge, RJ, Sheers, G.Effect of smoking on attack rates of pulmonary and pleural lesions related to exposure to asbestos dust. Br J Ind Med 1980;37(3):268–72.
Baker, EL, Dagg, T, Greene, RE.Respiratory illness in the construction trades. I. The significance of asbestos-associated pleural disease among sheet metal workers. J Occup Med 1985;27(7):483–9.
Viallat, JR, Boutin, C.Radiographic changes in chrysotile mine and mill ex-workers in Corsica. A survey 14 years after cessation of exposure. Lung 1980;157(3):155–63.
Jarvholm, B, Sanden, A.Estimating asbestos exposure: a comparison of methods. J Occup Med 1987;29(4):361–3.
Weiss, W, Levin, R, Goodman, L.Pleural plaques and cigarette smoking in asbestos workers. J Occup Med 1981;23:427–30.
Mitchev, K, Dumortier, P, De Vuyst, P.‘Black Spots’ and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Am J Surg Pathol 2002;26(9):1198–206.
Wang, N-S.The preformed stomas connecting the pleural cavity and the lymphatics of the pleura. Am Rev Respir Dis 1975;111:12–9.
Kanazawa, K, Roe, FJC, Yamamoto, T.Milky spots (taches laiteuses) as structures which trap asbestos in mesothelial layers and their significance in the pathogenesis of mesothelial neoplasia. Int J Cancer 1979;23:858–65.
Hillerdal, G.The pathogenesis of pleural plaques and pulmonary asbestosis: possibilities and impossibilities. Eur J Respir Dis 1980;61(3):129–38.
Monchaux, G, Bignon, J, Hirsch, A, Sebastian, P.Translocation of mineral fibres through the respiratory system after injection into the pleural cavity of rats. Ann Occup Hyg 1982;26:309–18.
Sebastien, P, Janson, X, Gaudichet, A, Hirsch, A, Bignon, J.Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura. IARC Sci Publ. 1980(30):237–46.
Meurman, LO.Pleural fibrocalcific plaques and asbestos exposure. Environ Res 1968;2(1):30–46.
Perkins, RC, Broaddus, VC, Shetty, S, Hamilton, S, Idell, S.Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells. Am J Respir Cell Mol Biol 1999;21(5):637–46.
Hirvonen, A, Saarikoski, ST, Linnainmaa, K, et al. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 1996;88(24):1853–6.
Neri, M, Ugolini, D, Dianzani, I, et al. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat Res. 2008 Feb 23.
Monaco, SE, Shuai, Y, Bansal, M, Krasinskas, AM, Dacic, S.The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations. Am J Clin Pathol 2011;135(4):619–27.
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4–1987. A 50-year-old man with recurrent pleuro-pulmonary abnormalities. N Engl J Med 1987;316(4):198–208.
Oliver, LC, Eisen, EA, Greene, R, Sprince, NL.Asbestos-related pleural plaques and lung function. Am J Ind Med 1988;14(6):649–56.
Bianchi, C, Brollo, A, Ramani, L, Zuch, C.Asbestos exposure in lung carcinoma: a necropsy-based study of 414 cases. Am J Ind Med 1999;36(3):360–4.
Fisher, MS.Asymmetrical changes in asbestos-related disease. J Can Assoc Radiol 1985;36(2):110–2.
Gallego, JC.Absence of left-sided predominance in asbestos-related pleural plaques: a CT study. Chest 1998;113(4):1034–6.
Andrion, A, Pira, E, Mollo, F.Peritoneal plaques and asbestos exposure. Arch Pathol Lab Med 1983;107(11):609–10.
Wain, SL, Roggli, VL, Foster, WL Jr.Parietal pleural plaques, asbestos bodies, and neoplasia. A clinical, pathologic, and roentgenographic correlation of 25 consecutive cases. Chest 1984;86(5):707–13.
Sison, RF, Hruban, RH, Moore, GW, et al. Pulmonary disease associated with pleural “asbestos” plaques. Chest 1989;95(4):831–5.
Hillerdal, G.Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. Chest 1994;105(1):144–50.
Hessel, PA, Gamble, JF, McDonald, JC.Asbestos, asbestosis, and lung cancer: a critical assessment of the epidemiological evidence. Thorax 2005;60(5):433–6.
Smith, DD.Plaques, cancer, and confusion. Chest 1994;105(1):8–9.
Guidotti, TL.Apportionment in asbestos-related disease for purposes of compensation. Ind Health 2002;40(4):295–311.
Mastrangelo, G, Ballarin, MN, Bellini, E, et al. Feasibility of a screening programme for lung cancer in former asbestos workers. Occup Med (Lond) 2008;58(3):175–80.
Weiss, W.Asbestos-related pleural plaques and lung cancer. Chest 1993;103(6):1854–9.
Roggli, VL, Sanders, LL.Asbestos content of lung tissue and carcinoma of the lung: a clinicopathologic correlation and mineral fiber analysis of 234 cases. Ann Occup Hyg 2000;44(2):109–17.
Partanen, T, Nurminen, M, Zitting, A, Koskinen, H, Wiikeri, M, Ahlman, K.Localized pleural plaques and lung cancer. Am J Ind Med 1992;22(2):185–92.
Bianchi, C, Brollo, A, Ramani, L, Zuch, C.Pleural plaques as risk indicators for malignant pleural mesothelioma: a necropsy-based study. Am J Ind Med 1997;32(5):445–9.
Koskinen, K, Pukkala, E, Martikainen, R, Reijula, K, Karjalainen, A.Different measures of asbestos exposure in estimating risk of lung cancer and mesothelioma among construction workers. J Occup Environ Med 2002;44(12):1190–6.
Epler, GR, McLoud, TC, Gaensler, EA.Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 1982;247(5):617–22.
Hillerdal, G.Non-malignant asbestos pleural disease. Thorax 1981;36(9):669–75.
Lilis, R, Lerman, Y, Selikoff, IJ.Symptomatic benign pleural effusions among asbestos insulation workers: residual radiographic abnormalities. Br J Ind Med 1988;45(7):443–9.
Hillerdal, G, Ozesmi, M.Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis 1987;71(2):113–21.
Shore, BL, Daughaday, CC, Spilberg, I.Benign asbestos pleurisy in the rabbit. A model for the study of pathogenesis. Am Rev Respir Dis 1983;128(3):481–5.
Hillerdal, G.Nonmalignant pleural disease related to asbestos exposure. Clin Chest Med 1985;6(1):141–52.
Cookson, WO, De Klerk, NH, Musk, AW, et al. Benign and malignant pleural effusions in former Wittenoom crocidolite millers and miners. Aust N Z J Med 1985;15(6):731–7.
Becklake, MR.Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice. Am Rev Respir Dis 1976;114(1):187–227.
Gaensler, EA, Kaplan, AI.Asbestos pleural effusion. Ann Intern Med 1971;74(2):178–91.
Martensson, G, Hagberg, S, Pettersson, K, Thiringer, G.Asbestos pleural effusion: a clinical entity. Thorax 1987;42(9):646–51.
Roggeri, A, Tomasi, C, Cavazza, A, Serra, L, Zucchi, L.Haemorrhagic pericardial effusion in an asbestos worker. Med Lav 2003;94(4):391–4.
American Thoracic Society. Medical Section of the American Lung Association: the diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis 1986;134(2):363–8.
Adelman, M, Albelda, SM, Gottlieb, J, Haponik, EF.Diagnostic utility of pleural fluid eosinophilia. Am J Med 1984;77(5):915–20.
Kishimoto, T, Okahara, M, Chikamori, K, et al. [Clinical evaluation of benign asbestos pleurisy]. Nihon Kokyuki Gakkai Zasshi 1998;36(1):18–22.
Chapman, SJ, Cookson, WO, Musk, AW, Lee, YC.Benign asbestos pleural diseases. Curr Opin Pulm Med 2003;9(4):266–71.
Martensson, G, Pettersson, K, Thiringer, G.Differentiation between malignant and non-malignant pleural effusion. Eur J Respir Dis 1985;67(5):326–34.
Begin, R.Asbestos-related disease. Eur Respir Mon 1999;11:168–9.
McLoud, TC, Woods, BO, Carrington, CB, Epler, GR, Gaensler, EA.Diffuse pleural thickening in an asbestos-exposed population: prevalence and causes. AJR Am J Roentgenol 1985;144(1):9–18.
Bohlig, H, Calavrezos, A.Development, radiological zone patterns, and importance of diffuse pleural thickening in relation to occupational exposure to asbestos. Br J Ind Med 1987;44(10):673–81.
Metintas, M, Metintas, S, Hillerdal, G, et al. Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study. Eur Respir J 2005;26(5):875–80.
Broaddus, VC, Everitt, JI, Black, B, Kane, AB.Non-neoplastic and neoplastic pleural endpoints following fiber exposure. J Toxicol Environ Health B Crit Rev 2011;14(1):153–78.
Gevenois, PA, de Maertelaer, V, Madani, A, et al. Asbestosis, pleural plaques and diffuse pleural thickening: three distinct benign responses to asbestos exposure. Eur Respir J 1998;11(5):1021–7.
Hillerdal, G.Asbestos related pleuropulmonary lesions and the erythrocyte sedimentation rate. Thorax 1984;39(10):752–8.
Kawamata, K, Haraoka, H, Hirohata, S, et al. Pleurisy in primary Sjogren's syndrome: T cell receptor beta-chain variable region gene bias and local autoantibody production in the pleural effusion. Clin Exp Rheumatol 1997;15(2):193–6.
Lapenas, D, Gale, P, Kennedy, T, Rawlings, W Jr, Dietrich, P.Kaolin pneumoconiosis. Radiologic, pathologic, and mineralogic findings. Am Rev Respir Dis 1984;130(2):282–8.
Tintner, R, Manian, P, Gauthier, P, Jankovic, J.Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease. Arch Neurol 2005;62(8):1290–5.
Marsaudon, E, Castet, D, Barrault, MF, Allais, C.[Diffuse interstitial lung disease without pleural involvement and high-dose bromocriptine]. Rev Mal Respir 1997;14(5):405–7.
Knoop, C, Mairesse, M, Lenclud, C, Gevenois, PA, De Vuyst, P.Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?Eur Respir J 1997;10(12):2898–901.
Hamada, K, Nagai, S, Kitaichi, M, et al. Cyclophosphamide-induced late-onset lung disease. Intern Med 2003;42(1):82–7.
Malik, SW, Myers, JL, DeRemee, RA, Specks, U.Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med 1996;154(6 Pt 1):1851–6.
Huggins, JT, Sahn, SA.Causes and management of pleural fibrosis. Respirology 2004;9(4):441–7.
Pezner, RD, Horak, DA, Sayegh, HO, Lipsett, JA.Spontaneous pneumothorax in patients irradiated for Hodgkin's disease and other malignant lymphomas. Int J Radiat Oncol Biol Phys 1990;18(1):193–8.
Buchanan, DR, Johnston, ID, Kerr, IH, et al. Cryptogenic bilateral fibrosing pleuritis. Br J Dis Chest 1988;82(2):186–93.
Navratil, M, Moravkova, K, Gafronova, M, Hruska, F.The fate of people with pleural hyalinosis (plaques): relationship to direct and indirect asbestos exposure. Czech Med 1988;11(3):146–56.
Kittredge, RD, Nash, AD.The many facets of sclerosing fibrosis. Am J Roentgenol Radium Ther Nucl Med 1974;122(2):288–98.
Hayes, JP, Wiggins, J, Ward, K, Muldowney, F, FitzGerald, MX.Familial cryptogenic fibrosing pleuritis with Fanconi's syndrome (renal tubular acidosis). A new syndrome. Chest 1995;107(2):576–8.
Azoulay, E, Paugam, B, Heymann, MF, et al. Familial extensive idiopathic bilateral pleural fibrosis. Eur Respir J 1999;14(4):971–3.
Uibu, T, Jarvenpaa, R, Hakomaki, J, et al. Asbestos-related pleural and lung fibrosis in patients with retroperitoneal fibrosis. Orphanet J Rare Dis 2008;3:29.
Miles, SE, Sandrini, A, Johnson, AR, Yates, DH.Clinical consequences of asbestos-related diffuse pleural thickening: A review. J Occup Med Toxicol 2008;3:20.
Yates, DH, Browne, K, Stidolph, PN, Neville, E.Asbestos-related bilateral diffuse pleural thickening: Natural history of radiographic and lung function abnormalities. Am J Respir Crit Care Med 1996;153:301–6.
Miller, A, Teirstein, AS, Selikoff, IJ.Ventilatory failure due to asbestos pleurisy. Am J Med 1983;75(6):911–9.
Mukherjee, S, de Klerk, N, Palmer, LJ, et al. Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease. Am J Respir Crit Care Med 2000;162(5):1807–11.
Park, EK, Thomas, PS, Johnson, AR, Yates, DH.Osteopontin levels in an asbestos-exposed population. Clin Cancer Res 2009;15(4):1362–6.
Hillerdal, G.Pleural changes and exposure to fibrous minerals. Scand J Work Environ Health 1984;10(6 Spec No):473–9.
Lynch, DA, Gamsu, G, Aberle, DR.Conventional and high resolution computed tomography in the diagnosis of asbestos-related diseases. Radiographics 1989;9(3):523–51.
Hillerdal, G, Malmberg, P, Hemmingsson, A.Asbestos-related lesions of the pleura: parietal plaques compared to diffuse thickening studied with chest roentgenography, computed tomography, lung function, and gas exchange. Am J Ind Med 1990;18(6):627–39.
Hu, H, Beckett, L, Kelsey, KDC.The left-sided predominance of asbestos-related pleural disease. Am Rev Respir Dis 1993;148:981–4.
Gibbs, AR, Stephens, M, Griffiths, DM, Blight, BJ, Pooley, FD.Fibre distribution in the lungs and pleura of subjects with asbestos related diffuse pleural fibrosis. Br J Ind Med 1991;48(11):762–70.
Sluis-Cremer, GK, Webster, I.Acute pleurisy in asbestos exposed persons. Environ Res 1972;5(4):380–92.
Solomon, A, Sluis-Cremer, GK, Goldstein, B.Visceral pleural plaque formation in asbestosis. Environ Res 1979;19(2):258–64.
Stephens, M, Gibbs, AR, Pooley, FD, Wagner, JC.Asbestos induced diffuse pleural fibrosis: pathology and mineralogy. Thorax 1987;42(8):583–8.
Letourneux, M.[Risk assessment of benign asbestosis (dose-effect relationship, time-effect relationship, co-factors)]. Rev Mal Respir 1999;16(6 Pt 2):1270–7.
Light, AM.Idiopathic fibrosis of mediastinum: a discussion of three cases and review of the literature. J Clin Pathol 1978;31(1):78–88.
Berry, DF, Buccigrossi, D, Peabody, J, Peterson, KL, Moser, KM.Pulmonary vascular occlusion and fibrosing mediastinitis. Chest 1986;89(2):296–301.
Rossiter, CE, Heath, JR, Harries, PG.Royal Naval dockyards asbestosis research project: nine-year follow-up study of men exposed to asbestos in Devonport Dockyard. J R Soc Med 1980;73(5):337–44.
de Klerk, NH, Cookson, WO, Musk, AW, Armstrong, BK, Glancy, JJ.Natural history of pleural thickening after exposure to crocidolite. Br J Ind Med 1989;46(7):461–7.
Rockoff, SD, Kagan, E, Schwartz, A, et al. Visceral pleural thickening in asbestos exposure: the occurrence and implications of thickened interlobar fissures. J Thorac Imaging 1987;2(4):58–66.
Browne, K, Smither, WJ.Asbestos-related mesothelioma: factors discriminating between pleural and peritoneal sites. Br J Ind Med 1983;40(2):145–52.
Reid, A, de Klerk, N, Ambrosini, G, et al. The additional risk of malignant mesothelioma in former workers and residents of Wittenoom with benign pleural disease or asbestosis. Occup Environ Med 2005;62(10):665–9.
de Klerk, NH, Musk, AW, Cookson, WO, Glancy, JJ, Hobbs, MS.Radiographic abnormalities and mortality in subjects with exposure to crocidolite. Br J Ind Med 1993;50(10):902–6.
de Klerk, NH, Musk, AW, Armstrong, BK, Hobbs, MS.Smoking, exposure to crocidolite, and the incidence of lung cancer and asbestosis. Br J Ind Med 1991;48(6):412–7.
Cox, G, Gauldie, J, Jordana, M.Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF) promote the survival of peripheral blood neutrophils in vitro. Am J Respir Cell Mol Biol 1992;7(5):507–13.
Nasreen, N, Mohammed, K, Sanders, K, et al. Differential expression of C-phos, C-June, and apoptosis in pleural mesothelial cells exposed to Staph.aureus. Am J Respir Crit Care Med 2001;163:A772.
Ozesmi, M, Hillerdal, G, Karlsson-Parra, A, Forsum, U.Phenotypes of peripheral blood lymphoid cells in patients with asbestos-related pleural lesions. Eur Respir J 1988;1(10):938–42.
Singh, B, Eastwood, PR, Finucane, KE, Panizza, JA, Musk, AW.Effect of asbestos-related pleural fibrosis on excursion of the lower chest wall and diaphragm. Am J Respir Crit Care Med 1999;160(5 Pt 1):1507–15.
Blesovsky, A.The folded lung. Br J Dis Chest 1966;60(1):19–22.
Mintzer, RA, Gore, RM, Vogelzang, RL, Holz, S.Rounded atelectasis and its association with asbestos-induced pleural disease. Radiology 1981;139(3):567–70.
Candura, SM, Binarelli, A, Ragno, G, Scafa, F.Two cases of asbestosis and one case of rounded atelectasis due to non-occupational asbestos exposure. Monaldi Arch Chest Dis 2008;69(1):35–8.
Kishimoto, T, Ozaki, S, Fujioka, H, et al. [Clinical evaluation of rounded atelectasis induced by exposure to asbestos]. Nihon Kokyuki Gakkai Zasshi 2002;40(2):95–100.
Chen, CH, Newman, L.Rounded atelectasis complicated by obstructive pneumonia and pulmonary arterial thrombosis. Chest 1990;98(5):1283–5.
Hillerdal, G.Rounded atelectasis. Clinical experience with 74 patients. Chest 1989;95(4):836–41.
Sasaki, M, Satoh, K, Fukunaga, K, et al. Rounded atelectasis formation following decrease of pleural effusion: a case report. Radiat Med 1996;14(6):331–3.
Hanke, R, Kretzschmar, R.Round atelectasis. Semin Roentgenol 1980;15(2):174–82.
Menzies, R, Fraser, R.Round atelectasis. Pathologic and pathogenetic features. Am J Surg Pathol 1987;11(9):674–81.
Dernevik, L, Gatzinsky, P.Pathogenesis of shrinking pleuritis with atelectasis – “rounded atelectasis”. Eur J Respir Dis 1987;71(4):244–9.
Cuasay, RS, Zehr, RD.Round atelectasis in an elderly man: the role of thoracotomy. Heart Lung 1986;15(2):202–4.
Srinivasan, AK, Holemans, JA, Page, RD.Two cases of rounded atelectasis presenting after coronary artery surgery. Ann Thorac Surg 2004;77(6):2190–2.
Kishi, K, Homma, S, Miyamoto, A, et al. Rounded atelectasis associated with pulmonary lymphangioleiomyomatosis. Intern Med 2005;44(6):625–7.
Kuno, R, Bower, DJ, Aguayo, SM.Round atelectasis as a complication of Legionnella pneumonia. Chest 1994;106(2):607–8.
Stark, P.Round atelectasis: another pulmonary pseudotumor. Am Rev Respir Dis 1982;125(2):248–50.
Yao, L, Killam, DA.Rounded atelectasis associated with end-stage renal disease. Chest 1989;96(2):441–3.
Dernevik, L, Gatzinsky, P, Hultman, E, et al. Shrinking pleuritis with atelectasis. Thorax 1982;37(4):252–8.
Bloom, CI, Wilson, GE.Rounded atelectasis and respiratory compromise secondary to pergolide use. Respirology 2009;14(6):906–7.
O'Donnell, DH, Phelan, S, McNicholas, W, et al. Idiopathic lymphocytic pleuritis: radiographic and high-resolution CT appearances and changes in response to therapy in two adults. Clin Imaging 2010;34(3):226–30.
Younis, WG, Dernaika, TA, Jones, KR, Kinasewitz, GT, Keddissi, JI.Rounded atelectasis with atypical computed tomography findings. Respir Care 2006;51(7):761–3.
Gevenois, P, De Vuyst, P, Vande, Weyer R.Tomodensitometries des pathologies thoraciques de l'amiante. Rev Im Med 1991;3:471–80.
Lynch, DA, Gamsu, G, Ray, CS, Aberle, DR.Asbestos-related focal lung masses: manifestations on conventional and high-resolution CT scans. Radiology 1988;169(3):603–7.
Melloni, B, Monteil, J, Vincent, F, et al. Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. Eur Respir J 2004;24(5):814–21.
Horn, M, Oechsner, M, Gardarsdottir, M, Kostler, H, Muller, MF.Dynamic contrast-enhanced MR imaging for differentiation of rounded atelectasis from neoplasm. J Magn Reson Imaging 2010;31(6):1364–70.
Miller, WT Jr, Gupta, PK, Grippi, MA, Miller, WT.Rounded atelectasis: diagnosis by fine-needle aspiration cytology. Diagn Cytopathol 1992;8(6):617–20.
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 24–1983. A 61-year-old man with a peripheral lung mass. N Engl J Med 1983;308(24):1466–72.
Roggli, V, Pratt, P, Brody, A.Analysis of tissue mineral fiber content. In Roggli, V, Greenberg, S, Pratt, P, eds. Pathology of Asbestos-Associated Diseases, 1st ed. Boston: Little, Brown, 1992.
Voisin, C, Fisekci, F, Voisin-Saltiel, S, et al. Asbestos-related rounded atelectasis. Radiologic and mineralogic data in 23 cases. Chest 1995;107(2):477–81.
Kishimoto, T, Gemba, K, Fujimoto, N, Nishi, H, Ozaki, S.[Evaluation of rounded atelectasis induced by exposure to asbestos]. Nihon Kokyuki Gakkai Zasshi 2008;46(9):707–11.
Munden, RF, Libshitz, HI.Rounded atelectasis and mesothelioma. AJR Am J Roentgenol 1998;170(6):1519–22.
Arakawa, H, Honma, K, Saito, Y, et al. Pleural disease in silicosis: pleural thickening, effusion, and invagination. Radiology 2005;236(2):685–93.
Stancato-Pasik, A, Mendelson, DS, Marom, Z.Rounded atelectasis caused by histoplasmosis. AJR Am J Roentgenol 1990;155(2):275–6.
Stathopoulos, GT, Karamessini, MT, Sotiriadi, AE, Pastromas, VG.Rounded atelectasis of the lung. Respir Med 2005;99(5):615–23.
Silverman, SP, Marino, PL.Unusual case of enlarging pulmonary mass. Chest 1987;91(3):457–8.
Bruyere, PJ, Bartsch, P, Ghaye, B.[Rounded atelectasis: a follow up of 10 years by CT]. Rev Med Liege 2005;60(10):767–71.
Nakagawa, Y, Shimazu, K, Ebihara, M, Amann, K.Rounded atelectasis that disappeared after bronchoscopy. Intern Med 1998;37(10):870–1.
Smith, LS, Schillaci, RF.Rounded atelectasis due to acute exudative effusion. Spontaneous resolution. Chest 1984;85(6):830–2.
Cagle, PT, Churg, A.Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies. Arch Pathol Lab Med 2005;129(11):1421–7.
Doyle, LA, Corson, JM, Sugarbaker, DJ, Chirieac, LR.High prevalence of atypical mesothelial proliferation in extrapleural pneumonectomy specimens; Further evidence of a potential precursor lesion to invasive mesothelioma. Mod Pathol 2010;23 suppl.1:401A.
Whitaker, D, Henderson, DW, Shilkin, KB.The concept of mesothelioma in situ: implications for diagnosis and histogenesis. Semin Diagn Pathol 1992;9(2):151–61.
Whitaker, D, Sterrett, G, Shilkin, K.Early diagnosis of malignant mesothelioma: the contribution of effusion and fine needle aspiration cytology and ancillary techniques. In Peters, G, Peters, B, eds. Asbestos Disease Update, March 1989. New York: Garland Law, 1989.
Henderson, DW, Shilkin, KB, Whitaker, D.Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review. Am J Clin Pathol 1998;110(3):397–404.
Henderson, D, Shilkin, K, Whitaker, D.The pathology of malignant mesothelioma including immunohistology and ultrastructure. In Henderson, D, Shilkin, K, Langlois, Sea, eds. Malignant Mesothelioma. New York: Hemisphere, 1991.
Galateau, Salle F, Le Stang, N, Verger, V, Attanoos, R, Cagle, P, Colby, T, et al. E-pathology and mesothelioma: the experience of the international mesothelioma panelHistopathology 2008; 53(special issue):343.
Churg, A, Colby, TV, Cagle, P, et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 2000;24(9):1183–200.
Churg, A, Cagle, PT, Roggli, V.Tumors of the Serosal Membranes, 4th series, Fascicle, 3rd ed. Washington DC: American Registry of Pathology, 2006.
Churg, A, Cagle, P, Roggli, V.Separation of Benign and Malignant Proliferations, 4th series, Fascicle, 3rd ed. Washington DC: American Registry of Pathology, 2006.
Agaimy, A.Benign mesothelial nodules within dermal vessels associated with huge umbilical hernia: a potential mimicker of malignancy. Am J Surg Pathol 2011;35(1):152–3.
Cury, PM, Butcher, DN, Corrin, B, Nicholson, AG.The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis. J Pathol 1999;189(2):251–7.
Attanoos, RL, Griffin, A, Gibbs, AR.The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology 2003;43(3):231–8.
Kradin, RL, Mark, EJ.Distinguishing benign mesothelial hyperplasia from neoplasia: a practical approach. Semin Diagn Pathol 2006;23(1):4–14.
Hurlimann, J.Desmin and neural marker expression in mesothelial cells and mesotheliomas. Hum Pathol 1994;25(8):753–7.
Wu, M, Sun, Y, Li, G, et al. Immunohistochemical detection of XIAP in mesothelium and mesothelial lesions. Am J Clin Pathol 2007;128(5):783–7.
Robinson, BW, Creaney, J, Lake, R, et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 2003;362(9396):1612–6.
Creaney, J, Yeoman, D, Demelker, Y, et al. Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma. J Thorac Oncol 2008;3(8):851–7.
Brock, MV, Hooker, CM, Yung, R, et al. Can we improve the cytologic examination of malignant pleural effusions using molecular analysis?Ann Thorac Surg 2005;80(4):1241–7.
Ladanyi, M.Implications of P16/CDKN2A deletion in pleural mesotheliomas. Lung Cancer 2005;49 Suppl 1:S95–8.
Monaco, S, Shuai, Y, Bansai, M, Krasinkas, A, Dacic, S.The diagnostic utility of p16FISH and GLUT-1 Immunohistochemistry in Mesothelial Proliferations. Mod Pathol 2011;24(Suppl.1):419A.
Wagner, JC, Sleggs, CA, Marchand, P.Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960;17:260–71.
Wagner, JC.The discovery of the association between blue asbestos and mesotheliomas and the aftermath. Br J Ind Med 1991;48(6):399–403.
Willis, RA.Pathology of Tumours. London: Butterworths, 1967.
Morgan, A, Evans, JC, Holmes, A.Deposition and clearance of inhaled fibrous minerals in the rat. Studies using radioactive tracer techniques. In Walton, WH, McGovern, B, eds. Inhaled Particles IV. New York: Pergamon Press, 1977.
Sebastien, P, Janson, S, Bonnaud, G.Translocation of Asbestos Fibers through the Respiratory Tract and Gastro-intestinal Tract according to Fiber Type and Size. Park Forest South, IL: Patotox, 1979.
Auerbach, O, Conston, AS, Garfinkel, L, Parks, VR, Kaslow, HD, Hammond, EC.Presence of asbestos bodies in organs other than the lung. Chest 1980;77(2):133–7.
HSE. Asbestos: medical guidance note. HSE Guidance Note MS 2003;13:1–8.
Hassan, R, Alexander, R.Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium. Hematol Oncol Clin North Am 2005;19(6):1067–87, vi.
Hammar, SP.Macroscopic, histologic, histochemical, immunohistochemical, and ultrastructural features of mesothelioma. Ultrastruct Pathol 2006;30(1):3–17.
Gutgemann, I, Standop, J, Fischer, HP.Primary intrahepatic malignant mesothelioma of epithelioid type. Virchows Arch 2006;448(5):655–8.
Moore, AJ, Parker, RJ, Wiggins, J.Malignant mesothelioma. Orphanet J Rare Dis 2008;3:34.
Camidge, DR, Stockton, DL, Bain, M.Factors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data. Br J Cancer 2006;95(5):649–52.
Iwatsubo, Y, Matrat, M, Michel, E, et al. Estimation of the incidence of pleural mesothelioma according to death certificates in France. Am J Ind Med 2002;42(3):188–99.
Rake, C, Gilham, C, Hatch, J, et al. Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer 2009;100(7):1175–83.
Peto, J, Hodgson, JT, Matthews, FE, Jones, JR.Continuing increase in mesothelioma mortality in Britain. Lancet 1995;345(8949):535–9.
Virta, R.Worldwide asbestos supply and consumption trends from 1900 through 2003. US Geological Survey Circular 1298.; 2006 [accessed 2010 May 13]; ].
Singhal, S, Kaiser, LR.Malignant mesothelioma: options for management. Surg Clin North Am 2002;82(4):797–831.
Leigh, J, Driscoll, T.Malignant mesothelioma in Australia, 1945–2002. Int J Occup Environ Health 2003;9(3):206–17.
Reid, A, Heyworth, J, de Klerk, NH, Musk, B.Cancer incidence among women and girls environmentally and occupationally exposed to blue asbestos at Wittenoom, Western Australia. Int J Cancer 2008;122(10):2337–44.
Reid, A, Berry, G, de Klerk, N, et al. Age and sex differences in malignant mesothelioma after residential exposure to blue asbestos (crocidolite). Chest 2007;131(2):376–82.
Musk, AW, de Klerk, NH.Epidemiology of malignant mesothelioma in Australia. Lung Cancer 2004;45 Suppl 1:S21–3.
Hyland, RA, Ware, S, Johnson, AR, Yates, DH.Incidence trends and gender differences in malignant mesothelioma in New South Wales, Australia. Scand J Work Environ Health 2007;33(4):286–92.
Bianchi, C, Bianchi, T.Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health 2007;45(3):379–87.
Kukreja, J, Jaklitsch, MT, Wiener, DC, et al. Malignant pleural mesothelioma: overview of the North American and European experience. Thorac Surg Clin 2004;14(4):435–45.
Peto, J, Decarli, A, La Vecchia, C, Levi, F, Negri, E.The European mesothelioma epidemic. Br J Cancer 1999;79(3–4):666–72.
Pelucchi, C, Malvezzi, M, La Vecchia, C, et al. The mesothelioma epidemic in Western Europe: an update. Br J Cancer 2004;90(5):1022–4.
Segura, O, Burdorf, A, Looman, C.Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 2003;60(1):50–5.
Bianchi, C, Brollo, A, Ramani, L, Bianchi, T.Malignant mesothelioma in central and Eastern Europe. Acta Med Croatica 2000;54(4–5):161–4.
Pitarque, S, Cleries, R, Martinez, JM, et al. Mesothelioma mortality in men: trends during 1977–2001 and projections for 2002–2016 in Spain. Occup Environ Med 2008;65(4):279–82.
Albin, M, Magnani, C, Krstev, S, Rapiti, E, Shefer, I.Asbestos and cancer: an overview of current trends in Europe. Environ Health Perspect 1999;107 Suppl 2:289–98.
Murayama, T, Takahashi, K, Natori, Y, Kurumatani, N.Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med 2006;49(1):1–7.
Murai, Y.Malignant mesothelioma in Japan: analysis of registered autopsy cases. Arch Environ Health 2001;56(1):84–8.
Tossavainen, A.Global use of asbestos and the incidence of mesothelioma. Int J Occup Environ Health 2004;10(1):22–5.
Mazurek, JM, Wood, JM.Asbestosis-related years of potential life lost before age 65 years – United States, 1968–2005. MMWR Morb Mortal Wkly Rep 2008;57:1321–5.
De Klerk, N, Armstrong, B, eds. The Epidemiology of Asbestos and Mesothelioma. New York: Hemisphere, 1992.
Hodgson, JT, Darnton, A.The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000;44(8):565–601.
Rodelsperger, K, Jockel, KH, Pohlabeln, H, Romer, W, Woitowitz, HJ.Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: results from a German hospital-based case-control study. Am J Ind Med 2001;39(3):262–75.
Fattman, C, ed. Experimental Models of Asbestos-Related Diseases, 2nd ed. New York: Springer, 2004.
World Trade Organization (WTO): European Communities – Measures Concerning Asbestos and Asbestos-containing Products. Geneva WTO; 2000. ()
Piolatto, G, Negri, E, La Vecchia, C, et al. An update of cancer mortality among chrysotile asbestos miners in Balangero, northern Italy. Br J Ind Med 1990;47(12):810–4.
Pira, E, Pelucchi, C, Piolatto, P, et al. Mortality from cancer and other causes in the Balangero cohort of chrysotile asbestos miners. Occup Environ Med 2009;66:805–9.
Groppo, C, Tomatis, M, Turci, F, et al. Potential toxicity of nonregulated asbestiform minerals: balangeroite from the western Alps. Part 1: Identification and characterization. J Toxicol Environ Health A 2005;68(1):1–19.
Turci, F, Tomatis, M, Gazzano, E, et al. Potential toxicity of nonregulated asbestiform minerals: balangeroite from the western Alps. Part 2: Oxidant activity of the fibers. J Toxicol Environ Health A 2005;68(1):21–39.
Lippmann, M.Asbestos exposure indices. Environ Res 1988;46(1):86–106.
Howel, D, Gibbs, A, Arblaster, L, et al. Mineral fibre analysis and routes of exposure to asbestos in the development of mesothelioma in an English region. Occup Environ Med 1999;56(1):51–8.
Landrigan, PJ, Nicholson, WJ, Suzuki, Y, Ladou, J.The hazards of chrysotile asbestos: a critical review. Ind Health 1999;37(3):271–80.
Goldberg, M, Imbernon, E, Rolland, P, et al. The French National Mesothelioma Surveillance Program. Occup Environ Med 2006;63(6):390–5.
Rolland, P, Gramond, C, Lacourt, A, et al. Occupations and industries in France at high risk for pleural mesothelioma: a population-based case-control study (1998–2002). Am J Ind Med 2010;53(12):1207–19.
McElvenny, DM, Darnton, AJ, Price, MJ, Hodgson, JT.Mesothelioma mortality in Great Britain from 1968 to 2001. Occup Med (Lond) 2005;55(2):79–87.
Ribak, J, Lilis, R, Suzuki, Y, Penner, L, Selikoff, IJ.Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death. Br J Ind Med 1988;45(3):182–7.
McDonald, AD, McDonald, JC.Mesothelioma after crocidolite exposure during gas mask manufacture. Environ Res 1978;17(3):340–6.
Jones, JS, Smith, PG, Pooley, FD, et al. The consequences of exposure to asbestos dust in a wartime gas-mask factory. IARC Sci Publ 1980(30):637–53.
McDonald, JC, Harris, JM, Berry, G.Sixty years on: the price of assembling military gas masks in 1940. Occup Environ Med 2006;63(12):852–5.
Teschke, K, Morgan, MS, Checkoway, H, et al. Mesothelioma surveillance to locate sources of exposure to asbestos. Can J Public Health 1997;88(3):163–8.
Sorahan, T.Mortality of UK oil refinery and petroleum distribution workers, 1951–2003. Occup Med (Lond) 2007;57(3):177–85.
Neumann, V, Gunthe, S, Mulle, KM, Fischer, M.Malignant mesothelioma – German mesothelioma register 1987–1999. Int Arch Occup Environ Health 2001;74(6):383–95.
Dodson, RF, Hammar, SP.Pleural mesothelioma in a woman whose documented past exposure to asbestos was from smoking asbestos-containing filtered cigarettes: the comparative value of analytical transmission electron microscopic analysis of lung and lymph-node tissue. Inhal Toxicol 2006;18(9):679–84.
McDonald, AD, Harper, A, McDonald, JC, el-Attar, OA.Epidemiology of primary malignant mesothelial tumors in Canada. Cancer 1970;26(4):914–9.
McDonald, AD, McDonald, JC.Malignant mesothelioma in North America. Cancer 1980;46(7):1650–6.
Hammond, EC, Selikoff, IJ, eds. Relation of cigarette smoking to risk of death of asbestos-associated disease among insulation workers in the United States. Biological Effects of Asbestos. Lyon: IARC, 1973.
Mensi, C, Macchione, M, Termine, L, et al. [Asbestos exposure in the non-asbestos textile industry: the experience of the Lombardy Mesothelioma Registry]. Epidemiol Prev 2007;31(4 Suppl 1):27–30.
Pesatori, AC, Mensi, C.Peculiar features of mesothelioma occurrence as related to exposure patterns and circumstances in the Lombard Region, Italy. Med Lav 2005;96(4):354–9.
Goodman, M, Teta, MJ, Hessel, PA, et al. Mesothelioma and lung cancer among motor vehicle mechanics: a meta-analysis. Ann Occup Hyg 2004;48(4):309–26.
Kelsh, MA, Craven, VA, Teta, MJ, Mowat, FS, Goodman, M.Mesothelioma in vehicle mechanics: is the risk different for Australians?Occup Med (Lond) 2007;57(8):581–9.
Kishimoto, T, Ozaki, S, Kato, K, Nishi, H, Genba, K.Malignant pleural mesothelioma in parts of Japan in relationship to asbestos exposure. Ind Health 2004;42(4):435–9.
Zellos, L, Christiani, DC.Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin 2004;14(4):469–77, viii.
Kielkowski, D, Nelson, G, Rees, D.Risk of mesothelioma from exposure to crocidolite asbestos: a 1995 update of a South African mortality study. Occup Environ Med 2000;57(8):563–7.
Abratt, RP, Vorobiof, DA, White, N.Asbestos and mesothelioma in South Africa. Lung Cancer 2004;45 Suppl 1:S3–6.
Rees, D, Goodman, K, Fourie, E, et al. Asbestos exposure and mesothelioma in South Africa. S Afr Med J 1999;89(6):627–34.
Decoufle, P.Mesothelioma among shoeworkers. Lancet 1980;1(8162):259.
Roggli, VL, McGavran, MH, Subach, J, Sybers, HD, Greenberg, SD.Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: a study of 25 cases. Cancer 1982;50(11):2423–32.
Brenner, J, Sordillo, PP, Magill, GB, Golbey, RB.Malignant mesothelioma of the pleura: review of 123 patients. Cancer 1982;49(11):2431–5.
Larson, T, Melnikova, N, Davis, SI, Jamison, P.Incidence and descriptive epidemiology of mesothelioma in the United States, 1999–2002. Int J Occup Environ Health 2007;13(4):398–403.
Gibbs, AR, Jones, JS, Pooley, FD, Griffiths, DM, Wagner, JC.Non-occupational malignant mesotheliomas. IARC Sci Publ 1989;(90):219–28.
Neumann, V, Rutten, A, Scharmach, M, Muller, KM, Fischer, M.Factors influencing long-term survival in mesothelioma patients – results of the German mesothelioma register. Int Arch Occup Environ Health 2004;77(3):191–9.
Dawson, A, Gibbs, AR, Pooley, FD, Griffiths, DM, Hoy, J.Malignant mesothelioma in women. Thorax 1993;48(3):269–74.
Huncharek, M, Capotorto, JV, Muscat, J.Domestic asbestos exposure, lung fibre burden, and pleural mesothelioma in a housewife. Br J Ind Med 1989;46(5):354–5.
Newhouse, ML, Thompson, H.Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area. Br J Ind Med 1965;22(4):261–9.
Vianna, NJ, Polan, AK.Non-occupational exposure to asbestos and malignant mesothelioma in females. Lancet 1978;1(8073):1061–3.
Joubert, L, Seidman, H, Selikoff, IJ.Mortality experience of family contacts of asbestos factory workers. Ann N Y Acad Sci 1991;643:416–8.
Bourdes, V, Boffetta, P, Pisani, P.Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Eur J Epidemiol 2000;16(5):411–7.
Magnani, C, Dalmasso, P, Biggeri, A, et al. Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferrato, Italy. Environ Health Perspect 2001;109(9):915–9.
Lee, RJ, Van Orden, DR.Airborne asbestos in buildings. Regul Toxicol Pharmacol 2008;50(2):218–25.
Perkins, RA, Hargesheimer, J, Fourie, W.Asbestos release from whole-building demolition of buildings with asbestos-containing material. J Occup Environ Hyg 2007;4(12):889–94.
Campopiano, A, Casciardi, S, Fioravanti, F, Ramires, D.Airborne asbestos levels in school buildings in Italy. J Occup Environ Hyg 2004;1(4):256–61.
Dumortier, P, Thimpont, J, de Maertelaer, V, De Vuyst, P.Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades. Eur Respir J 2003;22(3):519–24.
Burdett, GJ, Jaffrey, SA, Rood, AP.Airborne asbestos fibre levels in buildings: a summary of UK measurements. IARC Sci Publ 1989;(90):277–90.
Baris, YI, Grandjean, P.Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite. J Natl Cancer Inst 2006;98(6):414–7.
Baris, Y.The clinical and radiological aspects of 185 cases of malignant pleural mesothelioma. IARC Sci Publ 1980(30):937–47.
Baris, YI, Artvinli, M, Sahin, AA, et al.. Non-occupational asbestos related chest diseases in a small Anatolian village. Br J Ind Med 1988;45(12):841–2.
Dumortier, P, Coplu, L, Broucke, I, et al. Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzkoy, Cappadocia, Turkey. Occup Environ Med 2001;58(4):261–6.
Selcuk, ZT, Coplu, L, Emri, S, et al. Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey. Analysis of 135 cases. Chest 1992;102(3):790–6.
Galani, V, Constantopoulos, S, Manda-Stachouli, C, et al. Additional proteins in BAL fluid of Metsovites environmentally exposed to asbestos: more evidence of “protection” against neoplasia?Chest 2002;121(1):273–8.
Paoletti, L, Batisti, D, Bruno, C, et al. Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: an epidemiological and environmental study. Arch Environ Health 2000;55(6):392–8.
Hammond, EC, Garfinkel, L, Selikoff, IJ, Nicholson, WJ.Mortality experience of residents in the neighborhood of an asbestos factory. Ann N Y Acad Sci 1979;330:417–22.
Arblaster, L, Hatton, P, Howel, D, et al. Occupational and environmental links to mesothelioma deaths occurring in Leeds during 1971–1987. J Public Health Med 1995;17(3):297–304.
Epler, GR, Fitz, Gerald MX, Gaensler, EA, Carrington, CB.Asbestos-related disease from household exposure. Respiration 1980;39(4):229–40.
Kurumatani, N, Kumagai, S.Mapping the risk of mesothelioma due to neighborhood asbestos exposure. Am J Respir Crit Care Med 2008;178(6):624–9.
Heineman, EF, Bernstein, L, Stark, AD, Spirtas, R.Mesothelioma, asbestos, and reported history of cancer in first-degree relatives. Cancer 1996;77(3):549–54.
Bianchi, C, Brollo, A, Ramani, L, Bianchi, T, Giarelli, L.Familial mesothelioma of the pleura – a report of 40 cases. Ind Health 2004;42(2):235–9.
Ascoli, V, Cavone, D, Merler, E, et al. Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature. Am J Ind Med 2007;50(5):357–69.
Ugolini, D, Neri, M, Ceppi, M, et al. Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. Mutat Res 2008;658(3):162–71.
Grundy, GW, Miller, RW.Malignant mesothelioma in childhood. Report of 13 cases. Cancer 1972;30(5):1216–8.
Wassermann, M, Wassermann, D, Steinitz, R, Katz, L, Lemesch, C.Mesothelioma in children. IARC Sci Publ 1980;30:253–7.
Moran, CA, Albores-Saavedra, J, Suster, S.Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases. Histopathology 2008;52(7):824–30.
Boffetta, P.Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 2007;18(6):985–90.
Elmes, PC, Simpson, JC.The clinical aspects of mesothelioma. Q J Med 1976;45(179):427–49.
Amin, AM, Mason, C, Rowe, P.Diffuse malignant mesothelioma of the peritoneum following abdominal radiotherapy. Eur J Surg Oncol 2001;27(2):214–5.
Babcock, TL, Powell, DH, Bothwell, RS.Radiation-induced peritoneal mesothelioma. J Surg Oncol 1976;8(5):369–72.
Gilks, B, Hegedus, C, Freeman, H, Fratkin, L, Churg, A.Malignant peritoneal mesothelioma after remote abdominal radiation. Cancer 1988;61(10):2019–21.
Spirtas, R, Heineman, EF, Bernstein, L, et al. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med 1994;51(12):804–11.
Chahinian, AP, Pajak, TF, Holland, JF, et al. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med 1982;96(6 Pt 1):746–55.
Hershcovici, T, Chajek-Shaul, T, Hasin, T, et al. Familial Mediterranean fever and peritoneal malignant mesothelioma: a possible association?Isr Med Assoc J 2006;8(7):509–11.
Biggeri, A, Pasetto, R, Belli, S, et al. Mortality from chronic obstructive pulmonary disease and pleural mesothelioma in an area contaminated by natural fiber (fluoro-edenite). Scand J Work Environ Health 2004;30(3):249–52.
Andersson, M, Wallin, H, Jonsson, M, et al. Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status. Int J Cancer 1995;63(3):330–6.
Ishikawa, Y, Mori, T, Machinami, R.Lack of apparent excess of malignant mesothelioma but increased overall malignancies of peritoneal cavity in Japanese autopsies with Thorotrast injection into blood vessels. J Cancer Res Clin Oncol 1995;121(9–10):567–70.
Sanders, CL.Pleural mesothelioma in the rat following exposure to 239PuO2. Health Phys 1992;63(6):695–7.
Nakamura, E, Makishima, A, Hagino, K, Okabe, K.Accumulation of radium in ferruginous protein bodies formed in lung tissue: association of resulting radiation hotspots with malignant mesothelioma and other malignancies. Proc Jpn Acad Ser B Phys Biol Sci 2009;85(7):229–39.
Weissmann, LB, Corson, JM, Neugut, AI, Antman, KH.Malignant mesothelioma following treatment for Hodgkin's disease. J Clin Oncol 1996;14(7):2098–100.
Neugut, AI, Ahsan, H, Antman, KH.Incidence of malignant pleural mesothelioma after thoracic radiotherapy. Cancer 1997;80(5):948–50.
Cavazza, A, Travis, LB, Travis, WD, et al. Post-irradiation malignant mesothelioma. Cancer 1996;77(7):1379–85.
Barletta, JA, Godleski, J, Sugerbaker, DJ, Chireac, LR.Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin lymphomaMod Pathol 2010;23(Suppl. 1):397A–8A.
Travis, LB, Fossa, SD, Schonfeld, SJ, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005;97(18):1354–65.
Wagner, JC, Berry, G, Timbrell, V.Mesotheliomata in rats after inoculation with asbestos and other materials. Br J Cancer 1973;28(2):173–85.
Pott, F, Roller, M, Ziem, U, et al. Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats. IARC Sci Publ 1989(90):173–9.
Wheeler, CS.Exposure to man-made mineral fibers: a summary of current animal data. Toxicol Ind Health 1990;6(2):293–307.
De Vuyst, P, Dumortier, P, Swaen, GM, Pairon, JC, Brochard, P.Respiratory health effects of man-made vitreous (mineral) fibres. Eur Respir J 1995;8(12):2149–73.
Cicala, C, Pompetti, F, Carbone, M.SV40 induces mesotheliomas in hamsters. Am J Pathol 1993;142(5):1524–33.
Melnick, JL, Stinebaugh, S.Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med 1962;109:965–8.
Shah, KV, McCrumb, FR Jr, Daniel, RW, Ozer, HL.Serologic evidence for a simian-virus-40-like infection of man. J Natl Cancer Inst 1972;48(2):557–61.
Carbone, M, Pass, HI, Rizzo, P, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994;9(6):1781–90.
Mayall, FG, Jacobson, G, Wilkins, R.Mutations of p53 gene and SV40 sequences in asbestos associated and non-asbestos-associated mesotheliomas. J Clin Pathol 1999;52(4):291–3.
Rollison, DE, Page, WF, Crawford, H, Gridley, G, Wacholder, S, Martin, J, et al. Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine. Am J Epidemiol 2004;160(4):317–24.
Carbone, M.Association of Simian Virus 40 with Rodent and Human Mesotheliomas. Friedman H, ed. New York: Plenum Press, 1995.
Bergsagel, DJ, Finegold, MJ, Butel, JS, Kupsky, WJ, Garcea, RL.DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 1992;326(15):988–93.
Elmishad, AG, Bocchetta, M, Pass, HI, Carbone, M.Polio vaccines, SV40 and human tumours, an update on false positive and false negative results. Dev Biol (Basel) 2006;123:109–17; discussion 119–32.
Shah, KV.Causality of mesothelioma: SV40 question. Thorac Surg Clin 2004 Nov;14(4):497–504.
Shah, KV.SV40 and human cancer: a review of recent data. Int J Cancer 2007;120(2):215–23.
Gee, GV, Stanifer, ML, Christensen, BC, et al. SV40 associated miRNAs are not detectable in mesotheliomas. Br J Cancer 2010;103(6):885–8.
Pancaldi, C, Balatti, V, Guaschino, R, et al. Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution. J Infect 2009;58(1):53–60.
Lundstig, A, Dejmek, A, Eklund, C, Filinic, I, Dillner, J.No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden. Anticancer Res 2007;27(6B):4159–61.
Strickler, HD, Rosenberg, PS, Devesa, SS, et al. Contamination of poliovirus vaccines with simian virus 40 (1955–1963) and subsequent cancer rates. JAMA 1998;279(4):292–5.
Carbone, M, Rizzo, P, Pass, HI.Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 1997;15(16):1877–88.
Strickler, HD, Goedert, JJ, Devesa, SS, et al. Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst 2003;95(1):38–45.
Price, MJ, Darnton, AJ, McElvenny, DM, Hodgson, JT.Simian virus 40 and mesothelioma in Great Britain. Occup Med (Lond) 2007;57(8):564–8.
Manfredi, JJ, Dong, J, Liu, WJ, et al. Evidence against a role for SV40 in human mesothelioma. Cancer Res 2005;65(7):2602–9.
Lopez-Rios, F, Illei, PB, Rusch, V, Ladanyi, M.Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 2004;364(9440):1157–66.
Yang, H, Testa, JR, Carbone, M.Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr Treat Options Oncol 2008;9(2–3):147–57.
Boffetta, P.Health effects of asbestos exposure in humans: a quantitative assessment. Med Lav 1998;89(6):471–80.
Yates, DH, Corrin, B, Stidolph, PN, Browne, K.Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax 1997;52(6):507–12.
Rudd, RM.Malignant mesothelioma. Br Med Bull 2010;93:105–23.
Marinaccio, A, Binazzi, A, Cauzillo, G, et al. Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register. Eur J Cancer 2007;43(18):2722–8.
Niklinski, J, Niklinska, W, Chyczewska, E, et al. The epidemiology of asbestos-related diseases. Lung Cancer 2004;45 Suppl 1:S7–S15.
de Klerk, NH, Armstrong, BK.The epidemiology of asbestos and mesothelioma. In Henderson, DW, Shilkin, KB, Le P. Langlois, S, Whitaker, D, eds. Malignant Mesothelioma. New York: Hemisphere, 1992. pp. 223–50.
Ramos-Nino, ME, Testa, JR, Altomare, DA, et al. Cellular and molecular parameters of mesothelioma. J Cell Biochem 2006;98(4):723–34.
Manning, CB, Vallyathan, V, Mossman, BT.Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2002;2(2–3):191–200.
Kamp, DW, Weitzman, SA.The molecular basis of asbestos induced lung injury. Thorax 1999;54(7):638–52.
Swain, W, Mossman, B.Carcinogenetic mechanisms in mesothelioma: effects of asbestos on cell signalling events, transcription factors, and inflammatory cytokines. In O'ByrneKaR, V, ed. Malignant Pleural Mesothelioma. Oxford: Oxford University Press, 2006. pp. 129–61.
Mossman, BT, Bignon, J, Corn, M, Seaton, A, Gee, JB.Asbestos: scientific developments and implications for public policy. Science 1990;247(4940):294–301.
Mossman, BT, Kamp, DW, Weitzman, SA.Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest 1996;14(5):466–80.
Kamp, DW, Graceffa, P, Pryor, WA, Weitzman, SA.The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 1992;12(4):293–315.
Shukla, A, Gulumian, M, Hei, TK, et al. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med 2003;34(9):1117–29.
Hansen, K, Mossman, BT.Generation of superoxide (O2-.) from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res 1987;47(6):1681–6.
Asbestos in Public and Commercial Buildings: A Literature Reviewed Synthesis of Current Knowledge. Cambridge, MA: Health Effects Institute, 1991.
Weitzman, SA, Graceffa, P.Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch Biochem Biophys 1984;228(1):373–6.
Gulumian, M, van Wyk, JA.Hydroxyl radical production in the presence of fibres by a Fenton-type reaction. Chem Biol Interact 1987;62(1):89–97.
Chao, CC, Lund, LG, Zinn, KR, Aust, AE.Iron mobilization from crocidolite asbestos by human lung carcinoma cells. Arch Biochem Biophys 1994;314(2):384–91.
Fang, R, Aust, AE.Induction of ferritin synthesis in human lung epithelial cells treated with crocidolite asbestos. Arch Biochem Biophys 1997;340(2):369–75.
Rom, WN, Travis, WD, Brody, AR.Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis 1991;143(2):408–22.
Mossman, BT, Churg, A.Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998;157(5 Pt 1):1666–80.
Churg, A.The uptake of mineral particles by pulmonary epithelial cells. Am J Respir Crit Care Med 1996;154(4 Pt 1):1124–40.
Toyokuni, S.Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996;20(4):553–66.
Weiss, SJ.Tissue destruction by neutrophils. N Engl J Med 1989;320(6):365–76.
Vainio, H, Boffetta, P.Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer. Scand J Work Environ Health 1994;20(4):235–42.
Kinnula, VL.Oxidant and antioxidant mechanisms of lung disease caused by asbestos fibres. Eur Respir J 1999;14(3):706–16.
Shukla, A, Flanders, T, Lounsbury, KM, Mossman, BT.The gamma-glutamylcysteine synthetase and glutathione regulate asbestos-induced expression of activator protein-1 family members and activity. Cancer Res 2004;64(21):7780–6.
Kamp, DW, Israbian, VA, Preusen, SE, Zhang, CX, Weitzman, SA.Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: role of iron-catalyzed free radicals. Am J Physiol 1995;268(3 Pt 1):L471–80.
Lesur, O, Bouhadiba, T, Melloni, B, et al. Alterations of surfactant lipid turnover in silicosis: evidence of a role for surfactant-associated protein A (SP-A). Int J Exp Pathol 1995;76(4):287–98.
Fung, H, Kow, YW, Van Houten, B, Mossman, BT.Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidative stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos. Carcinogenesis 1997;18(4):825–32.
Pass, HI, Mew, DJ, Carbone, M, et al. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor. Cancer Res 1996;56(17):4044–8.
Hardy, JA, Aust, AE.The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis 1995;16(2):319–25.
Pache, JC, Janssen, YM, Walsh, ES, et al. Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers. Am J Pathol 1998;152(2):333–40.
Ramos-Nino, ME, Timblin, CR, Mossman, BT.Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression. Cancer Res 2002;62(21):6065–9.
Janssen, YM, Barchowsky, A, Treadwell, M, Driscoll, KE, Mossman, BT.Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci USA 1995;92(18):8458–62.
Janssen, YM, Driscoll, KE, Howard, B, et al. Asbestos causes translocation of p65 protein and increases NF-kappa B DNA binding activity in rat lung epithelial and pleural mesothelial cells. Am J Pathol 1997;151(2):389–401.
Heintz, NH, Janssen, YM, Mossman, BT.Persistent induction of c-fos and c-jun expression by asbestos. Proc Natl Acad Sci USA 1993;90(8):3299–303.
Kahlos, K, Pitkanen, S, Hassinen, I, Linnainmaa, K, Kinnula, VL.Generation of reactive oxygen species by human mesothelioma cells. Br J Cancer 1999;80(1–2):25–31.
Ramos-Nino, ME, Haegens, A, Shukla, A, Mossman, BT.Role of mitogen-activated protein kinases (MAPK) in cell injury and proliferation by environmental particulates. Mol Cell Biochem 2002;234–235(1–2):111–8.
Marrogi, A, Pass, HI, Khan, M, et al. Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor. Cancer Res 2000;60(14):3696–700.
Edwards, JG, Faux, SP, Plummer, SM, et al. Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma. Clin Cancer Res 2002;8(6):1857–62.
Soini, Y, Puhakka, A, Kahlos, K, et al. Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1. Histopathology 2001;39(2):179–86.
Sun, X, Dobra, K, Bjornstedt, M, Hjerpe, A.Upregulation of 9 genes, including that for thioredoxin, during epithelial differentiation of mesothelioma cells. Differentiation 2000;66(4–5):181–8.
Romano, M, Catalano, A, Nutini, M, et al. 5-lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor. FASEB J 2001;15(13):2326–36.
Broaddus, VC, Yang, L, Scavo, LM, Ernst, JD, Boylan, AM.Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J Clin Invest 1996;98(9):2050–9.
Goldberg, JL, Zanella, CL, Janssen, YM, et al. Novel cell imaging techniques show induction of apoptosis and proliferation in mesothelial cells by asbestos. Am J Respir Cell Mol Biol 1997;17(3):265–71.
BeruBe, KA, Quinlan, TR, Fung, H, et al. Apoptosis is observed in mesothelial cells after exposure to crocidolite asbestos. Am J Respir Cell Mol Biol 1996;15(1):141–7.
Shukla, A, Jung, M, Stern, M, et al. Asbestos induces mitochondrial DNA damage and dysfunction linked to the development of apoptosis. Am J Physiol Lung Cell Mol Physiol 2003;285(5):L1018–25.
Panduri, V, Weitzman, SA, Chandel, N, Kamp, DW.The mitochondria-regulated death pathway mediates asbestos-induced alveolar epithelial cell apoptosis. Am J Respir Cell Mol Biol 2003;28(2):241–8.
Janssen, YM, Matalon, S, Mossman, BT.Differential induction of c-fos, c-jun, and apoptosis in lung epithelial cells exposed to ROS or RNS. Am J Physiol 1997;273(4 Pt 1):L789–96.
Hockenbery, DM, Oltvai, ZN, Yin, XM, Milliman, CL, Korsmeyer, SJ.Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75(2):241–51.
Kane, DJ, Sarafian, TA, Anton, R, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993;262(5137):1274–7.
Hagar, H, Ueda, N, Shah, SV.Role of reactive oxygen metabolites in DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells. Am J Physiol 1996;271(1 Pt 2):F209–15.
McGowan, AJ, Ruiz-Ruiz, MC, Gorman, AM, Lopez-Rivas, A, Cotter, TG.Reactive oxygen intermediate(s) (ROI): common mediator(s) of poly(ADP-ribose)polymerase (PARP) cleavage and apoptosis. FEBS Lett 1996;392(3):299–303.
White, E.Life, death, and the pursuit of apoptosis. Genes Dev 1996;10(1):1–15.
Narasimhan, SR, Yang, L, Gerwin, BI, Broaddus, VC.Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax. Am J Physiol 1998;275(1 Pt 1):L165–71.
Kahlos, K, Anttila, S, Asikainen, T, et al. Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma. Am J Respir Cell Mol Biol 1998;18(4):570–80.
Manna, SK, Zhang, HJ, Yan, T, Oberley, LW, Aggarwal, BB.Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem 1998;273(21):13245–54.
Zwacka, RM, Dudus, L, Epperly, MW, Greenberger, JS, Engelhardt, JF.Redox gene therapy protects human IB-3 lung epithelial cells against ionizing radiation-induced apoptosis. Hum Gene Ther 1998;9(9):1381–6.
Kamp, DW, Dunne, M, Anderson, JA, Weitzman, SA, Dunn, MM.Serum promotes asbestos-induced injury to human pulmonary epithelial cells. J Lab Clin Med 1990;116(3):289–97.
Robinson, MJ, Cobb, MH.Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997;9(2):180–6.
Xia, Z, Dickens, M, Raingeaud, J, Davis, RJ, Greenberg, ME.Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270(5240):1326–31.
Zanella, CL, Posada, J, Tritton, TR, Mossman, BT.Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Res 1996;56(23):5334–8.
Sekido, Y.Molecular biology of malignant mesothelioma. Environ Health Prev Med 2008;13(2):65–70.
Jaurand, MC.Mechanisms of fiber-induced genotoxicity. Environ Health Perspect 1997;105 Suppl 5:1073–84.
Pylkkanen, L, Wolff, H,